I	B-protein
kappa	I-protein
B/MAD-3	I-protein
masks	O
the	O
nuclear	O
localization	O
signal	O
of	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
and	O
requires	O
the	O
transactivation	B-protein
domain	I-protein
to	O
inhibit	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
DNA	O
binding	O
.	O

The	O
active	O
nuclear	O
form	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factor	I-protein
complex	I-protein
is	O
composed	O
of	O
two	O
DNA	B-protein
binding	I-protein
subunits	I-protein
,	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
and	O
NF-kappa	B-protein
B	I-protein
p50	I-protein
,	O
both	O
of	O
which	O
share	O
extensive	O
N-terminal	O
sequence	O
homology	O
with	O
the	O
v-rel	B-protein
oncogene	I-protein
product	I-protein
.	O

The	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
subunit	I-protein
provides	O
the	O
transactivation	O
activity	O
in	O
this	O
complex	O
and	O
serves	O
as	O
an	O
intracellular	O
receptor	O
for	O
a	O
cytoplasmic	O
inhibitor	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
termed	O
I	O
kappa	O
B	O
.	O

In	O
contrast	O
,	O
NF-kappa	B-protein
B	I-protein
p50	I-protein
alone	O
fails	O
to	O
stimulate	O
kappa	O
B-directed	O
transcription	O
,	O
and	O
based	O
on	O
prior	O
in	O
vitro	O
studies	O
,	O
is	O
not	O
directly	O
regulated	O
by	O
I	B-protein
kappa	I-protein
B	I-protein
.	O

To	O
investigate	O
the	O
molecular	O
basis	O
for	O
the	O
critical	O
regulatory	O
interaction	O
between	O
NF-kappa	B-protein
B	I-protein
and	O
I	B-protein
kappa	I-protein
B/MAD-3	I-protein
,	O
a	O
series	O
of	O
human	B-protein
NF-kappa	I-protein
B	I-protein
p65	I-protein
mutants	I-protein
was	O
identified	O
that	O
functionally	O
segregated	O
DNA	O
binding	O
,	O
I	B-protein
kappa	I-protein
B	I-protein
-mediated	O
inhibition	O
,	O
and	O
I	B-protein
kappa	I-protein
B	I-protein
-induced	O
nuclear	O
exclusion	O
of	O
this	O
transcription	B-protein
factor	I-protein
.	O

Results	O
from	O
in	O
vivo	O
expression	O
studies	O
performed	O
with	O
these	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
mutants	I-protein
revealed	O
the	O
following	O
:	O
1	O
)	O
I	B-protein
kappa	I-protein
B/MAD-3	I-protein
completely	O
inhibits	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
-dependent	O
transcriptional	O
activation	O
mediated	O
through	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
kappa	I-DNA
B	I-DNA
enhancer	I-DNA
in	O
human	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
,	O
2	O
)	O
the	O
binding	O
of	O
I	B-protein
kappa	I-protein
B/MAD-3	I-protein
to	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
is	O
sufficient	O
to	O
retarget	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
,	O
3	O
)	O
selective	O
deletion	O
of	O
the	O
functional	O
nuclear	O
localization	O
signal	O
present	O
in	O
the	O
Rel	B-protein
homology	I-protein
domain	I-protein
of	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
disrupts	O
its	O
ability	O
to	O
engage	O
I	B-protein
kappa	I-protein
B/MAD-3	I-protein
,	O
and	O
4	O
)	O
the	O
unique	O
C-terminus	B-protein
of	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
attenuates	O
its	O
own	O
nuclear	O
localization	O
and	O
contains	O
sequences	O
that	O
are	O
required	O
for	O
I	B-protein
kappa	I-protein
B	I-protein
-mediated	O
inhibition	O
of	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
DNA	O
binding	O
activity	O
.	O

Together	O
,	O
these	O
findings	O
suggest	O
that	O
the	O
nuclear	O
localization	O
signal	O
and	O
transactivation	B-protein
domain	I-protein
of	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
constitute	O
a	O
bipartite	O
system	O
that	O
is	O
critically	O
involved	O
in	O
the	O
inhibitory	O
function	O
of	O
I	B-protein
kappa	I-protein
B/MAD-3	I-protein
.	O

Unexpectedly	O
,	O
our	O
in	O
vivo	O
studies	O
also	O
demonstrate	O
that	O
I	B-protein
kappa	I-protein
B/MAD-3	I-protein
binds	O
directly	O
to	O
NF-kappa	B-protein
B	I-protein
p50	I-protein
.	O

This	O
interaction	O
is	O
functional	O
as	O
it	O
leads	O
to	O
retargeting	O
of	O
NF-kappa	B-protein
B	I-protein
p50	I-protein
from	O
the	O
nucleus	O
to	O
the	O
cytoplasm	O
.	O

However	O
,	O
no	O
loss	O
of	O
DNA	O
binding	O
activity	O
is	O
observed	O
,	O
presumably	O
reflecting	O
the	O
unique	O
C-terminal	B-protein
domain	I-protein
that	O
is	O
distinct	O
from	O
that	O
present	O
in	O
NF-kappa	B-protein
B	I-protein
p65	I-protein
.	O

Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
1339-1352	NULL
,	NULL
December	NULL
1992	NULL
I	NULL
«	NULL
xB/MAD-3	NULL
Masks	NULL
the	NULL
Nuclear	NULL
Localization	NULL
Signal	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
Requires	NULL
the	NULL
Transactivation	NULL
Domain	NULL
to	NULL
Inhibit	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
Binding	NULL
Parham	NULL
A.	NULL
Ganchi	NULL
,	NULL
Shao-Cong	NULL
Sun	NULL
,	NULL
Warner	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
Dean	NULL
W.	NULL
Ballard*	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
General	NULL
Hospital	NULL
,	NULL
California	NULL
94141-9100	NULL
Submitted	NULL
August	NULL
14	NULL
,	NULL
1992	NULL
;	NULL
Accepted	NULL
September	NULL
23	NULL
,	NULL
1992	NULL
The	NULL
active	NULL
nuclear	NULL
form	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
DNA	NULL
binding	NULL
subunits	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
both	NULL
of	NULL
which	NULL
share	NULL
extensive	NULL
N-terminal	NULL
sequence	NULL
homology	NULL
with	NULL
the	NULL
v-rel	NULL
oncogene	NULL
product	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
subunit	NULL
provides	NULL
the	NULL
transactivation	NULL
activity	NULL
in	NULL
this	NULL
complex	NULL
and	NULL
serves	NULL
as	NULL
an	NULL
intracellular	NULL
receptor	NULL
for	NULL
a	NULL
cytoplasmic	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
termed	NULL
IkB	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
alone	NULL
fails	NULL
to	NULL
stimulate	NULL
«	NULL
B-directed	NULL
transcription	NULL
,	NULL
and	NULL
based	NULL
on	NULL
prior	NULL
in	NULL
vitro	NULL
studies	NULL
,	NULL
is	NULL
not	NULL
directly	NULL
regulated	NULL
by	NULL
IkB	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
critical	NULL
regulatory	NULL
interaction	NULL
between	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
IxB/MAD-3	NULL
,	NULL
a	NULL
series	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutants	NULL
was	NULL
identified	NULL
that	NULL
functionally	NULL
segregated	NULL
DNA	NULL
binding	NULL
,	NULL
IxB-mediated	NULL
inhibition	NULL
,	NULL
and	NULL
IxB-induced	NULL
nuclear	NULL
exclusion	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

Results	NULL
from	NULL
in	NULL
vivo	NULL
expression	NULL
studies	NULL
performed	NULL
with	NULL
these	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutants	NULL
revealed	NULL
the	NULL
following	NULL
:	NULL
1	NULL
)	NULL
IxB/MAD-3	NULL
completely	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
p65-dependent	NULL
transcriptional	NULL
activation	NULL
mediated	NULL
through	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
«	NULL
B	NULL
enhancer	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
2	NULL
)	NULL
the	NULL
binding	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
sufficient	NULL
to	NULL
retarget	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
,	NULL
3	NULL
)	NULL
selective	NULL
deletion	NULL
of	NULL
the	NULL
functional	NULL
nuclear	NULL
localization	NULL
signal	NULL
present	NULL
in	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
disrupts	NULL
its	NULL
ability	NULL
to	NULL
engage	NULL
IxB/MAD-3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
the	NULL
unique	NULL
C-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
attenuates	NULL
its	NULL
own	NULL
nuclear	NULL
localization	NULL
and	NULL
contains	NULL
sequences	NULL
that	NULL
are	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
and	NULL
transactivation	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
constitute	NULL
a	NULL
bipartite	NULL
system	NULL
that	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
inhibitory	NULL
function	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

Unexpectedly	NULL
,	NULL
our	NULL
in	NULL
vivo	NULL
studies	NULL
also	NULL
demonstrate	NULL
that	NULL
IxB/MAD-3	NULL
binds	NULL
directly	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
functional	NULL
as	NULL
it	NULL
leads	NULL
to	NULL
retargeting	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
from	NULL
the	NULL
nucleus	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

However	NULL
,	NULL
no	NULL
loss	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
observed	NULL
,	NULL
presumably	NULL
reflecting	NULL
the	NULL
unique	NULL
C-terminal	NULL
domain	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

INTRODUCTION	NULL
During	NULL
the	NULL
development	NULL
of	NULL
a	NULL
normal	NULL
immune	NULL
response	NULL
,	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
activated	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
is	NULL
tightly	NULL
controlled	NULL
by	NULL
the	NULL
transient	NULL
transcriptional	NULL
in	NULL
*	NULL
Corresponding	NULL
author	NULL
and	NULL
present	NULL
address	NULL
:	NULL
Dean	NULL
W.	NULL
Ballard	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
,	NULL
802	NULL
Light	NULL
Hall	NULL
,	NULL
Nashville	NULL
,	NULL
TN	NULL
37232-0295	NULL
.	NULL

©	NULL
1992	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Cell	NULL
Biology	NULL
duction	NULL
of	NULL
specific	NULL
cellular	NULL
genes	NULL
,	NULL
including	NULL
those	NULL
encoding	NULL
the	NULL
growth	NULL
factor	NULL
interleukin-2	NULL
and	NULL
the	NULL
alpha	NULL
subunit	NULL
of	NULL
its	NULL
high-affinity	NULL
membrane	NULL
receptor	NULL
complex	NULL
(	NULL
Crabtree	NULL
,	NULL
1989	NULL
;	NULL
Greene	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
growth-related	NULL
genes	NULL
contain	NULL
promoter-proximal	NULL
regulatory	NULL
sequences	NULL
that	NULL
serve	NULL
as	NULL
functional	NULL
binding	NULL
sites	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Bohnlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Hoyos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
a	NULL
heterodimeric	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
rapidly	NULL
trans-located	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
during	NULL
T-cell	NULL
1339	NULL
P.A	NULL
.	NULL

Ganchi	NULL
et	NULL
al	NULL
.	NULL

activation	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986a	NULL
,	NULL
b	NULL
;	NULL
Lenardo	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
)	NULL
.	NULL

Like	NULL
these	NULL
inducible	NULL
cellular	NULL
transcription	NULL
units	NULL
,	NULL
the	NULL
5	NULL
'	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
'	NULL
of	NULL
the	NULL
type	NULL
1	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV-1	NULL
)	NULL
contains	NULL
two	NULL
tandem	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
that	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
capacity	NULL
of	NULL
this	NULL
pathogenic	NULL
retrovirus	NULL
to	NULL
respond	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
immunomodulatory	NULL
signals	NULL
that	NULL
normally	NULL
lead	NULL
to	NULL
T-cell	NULL
activation	NULL
(	NULL
Kaufman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
;	NULL
Siek-evitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Tong-Starksen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
represents	NULL
one	NULL
critical	NULL
host	NULL
transcription	NULL
factor	NULL
involved	NULL
not	NULL
only	NULL
in	NULL
normal	NULL
T-cell	NULL
activation	NULL
and	NULL
growth	NULL
but	NULL
also	NULL
in	NULL
governing	NULL
the	NULL
initial	NULL
activation	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
virally-infected	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
(	NULL
Greene	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Biochemical	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
)	NULL
and	NULL
molecular	NULL
cloning	NULL
(	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
heterodimeric	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
found	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
is	NULL
comprised	NULL
of	NULL
at	NULL
least	NULL
two	NULL
DNA	NULL
binding	NULL
subunits	NULL
,	NULL
termed	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
subunits	NULL
share	NULL
significant	NULL
N-terminal	NULL
amino	NULL
acid	NULL
sequence	NULL
homology	NULL
(	NULL
~300	NULL
amino	NULL
acids	NULL
)	NULL
with	NULL
the	NULL
v-Rel	NULL
oncoprotein	NULL
,	NULL
its	NULL
cellular	NULL
counterpart	NULL
(	NULL
c-Rel	NULL
)	NULL
,	NULL
and	NULL
the	NULL
dorsal	NULL
gene	NULL
product	NULL
,	NULL
a	NULL
maternal	NULL
morphogen	NULL
in	NULL
Drosophila	NULL
(	NULL
Gilmore	NULL
,	NULL
1990	NULL
,	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
subunit	NULL
exhibits	NULL
two	NULL
unique	NULL
biologic	NULL
activities	NULL
that	NULL
are	NULL
integral	NULL
to	NULL
the	NULL
function	NULL
and	NULL
regulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
.	NULL

First	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
unlike	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
contains	NULL
a	NULL
strong	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
that	NULL
is	NULL
essential	NULL
for	NULL
efficient	NULL
transcription	NULL
directed	NULL
from	NULL
the	NULL
HIV-1	NULL
«	NULL
kB	NULL
enhancer	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
this	NULL
subunit	NULL
acts	NULL
as	NULL
an	NULL
intracellular	NULL
receptor	NULL
for	NULL
I	NULL
«	NULL
B	NULL
,	NULL
a	NULL
specific	NULL
cytoplasmic	NULL
inhibitor	NULL
that	NULL
appears	NULL
critically	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
shuttling	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
during	NULL
T-cell	NULL
activation	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988a	NULL
,	NULL
b	NULL
;	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
positive	NULL
transcriptional	NULL
effects	NULL
exerted	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
comparative	NULL
studies	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
have	NULL
suggested	NULL
that	NULL
it	NULL
primarily	NULL
serves	NULL
to	NULL
augment	NULL
the	NULL
DNA	NULL
binding	NULL
affinity	NULL
of	NULL
the	NULL
heterodimeric	NULL
NF-	NULL
«	NULL
B	NULL
p65/p50	NULL
complex	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
also	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
homodimeric	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
acts	NULL
as	NULL
a	NULL
physiologic	NULL
repressor	NULL
of	NULL
«	NULL
B-dependent	NULL
transcription	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Kang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
despite	NULL
its	NULL
extensive	NULL
N-terminal	NULL
sequence	NULL
homology	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
is	NULL
not	NULL
subject	NULL
'	NULL
Abbreviations	NULL
used	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
DTT	NULL
,	NULL
dithiothreitol	NULL
;	NULL
FCS	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
;	NULL
HEPES	NULL
,	NULL
N-2-hydroxyethylpi-perazine-N'-2-ethanesulfonic	NULL
acid	NULL
;	NULL
HIV-1	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
;	NULL
HTLV-1	NULL
,	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
;	NULL
LTR	NULL
,	NULL
long	NULL
terminal	NULL
repeat	NULL
;	NULL
NLS	NULL
,	NULL
nuclear	NULL
localization	NULL
signal	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
PKA	NULL
,	NULL
protein	NULL
kinase	NULL
A	NULL
;	NULL
SDS	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
.	NULL

1340	NULL
to	NULL
IxB-mediated	NULL
inhibition	NULL
in	NULL
vitro	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Zabel	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
is	NULL
expressed	NULL
as	NULL
an	NULL
inactive	NULL
110-kDa	NULL
precursor	NULL
polypeptide	NULL
whose	NULL
DNA	NULL
binding	NULL
potential	NULL
is	NULL
regulated	NULL
via	NULL
proteolytic	NULL
processing	NULL
to	NULL
remove	NULL
an	NULL
inhibitory	NULL
C-terminal	NULL
domain	NULL
(	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
transactivation	NULL
and	NULL
IxB	NULL
binding	NULL
properties	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
are	NULL
clearly	NULL
distinct	NULL
from	NULL
those	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
the	NULL
molecular	NULL
mechanism	NULL
underlying	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
specifically	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
subunit	NULL
(	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
)	NULL
remains	NULL
unknown	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
long-range	NULL
deletion	NULL
mapping	NULL
studies	NULL
with	NULL
in	NULL
vitro	NULL
synthesized	NULL
proteins	NULL
suggest	NULL
that	NULL
the	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
contains	NULL
structural	NULL
determinants	NULL
essential	NULL
for	NULL
its	NULL
regulation	NULL
by	NULL
I	NULL
«	NULL
B	NULL
(	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

To	NULL
define	NULL
precisely	NULL
this	NULL
critical	NULL
regulatory	NULL
interaction	NULL
in	NULL
a	NULL
more	NULL
physiologic	NULL
setting	NULL
,	NULL
we	NULL
have	NULL
analyzed	NULL
the	NULL
biochemical	NULL
properties	NULL
of	NULL
a	NULL
series	NULL
of	NULL
in	NULL
vivo	NULL
synthesized	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
variants	NULL
after	NULL
transfection	NULL
of	NULL
the	NULL
corresponding	NULL
cDNA	NULL
expression	NULL
vectors	NULL
in	NULL
monkey	NULL
COS	NULL
cells	NULL
.	NULL

These	NULL
studies	NULL
clearly	NULL
demonstrate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
contains	NULL
two	NULL
domains	NULL
that	NULL
function	NULL
in	NULL
concert	NULL
to	NULL
mediate	NULL
assembly	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Specifically	NULL
,	NULL
one	NULL
major	NULL
subregion	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
critically	NULL
involved	NULL
in	NULL
I	NULL
«	NULL
B/MAD-3	NULL
binding	NULL
corresponds	NULL
to	NULL
the	NULL
functional	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
NLS	NULL
)	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
but	NULL
is	NULL
completely	NULL
dispensible	NULL
for	NULL
the	NULL
assembly	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

Surprisingly	NULL
,	NULL
I	NULL
«	NULL
B/MAD-3	NULL
also	NULL
binds	NULL
to	NULL
and	NULL
regulates	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
the	NULL
structurally	NULL
related	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
subunit	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
IxB/	NULL
MAD-3	NULL
prevents	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
directly	NULL
masking	NULL
the	NULL
NLS	NULL
of	NULL
either	NULL
of	NULL
these	NULL
integral	NULL
Rel-related	NULL
subunits	NULL
.	NULL

However	NULL
,	NULL
the	NULL
selective	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
occurs	NULL
through	NULL
a	NULL
more	NULL
complex	NULL
interaction	NULL
involving	NULL
the	NULL
unique	NULL
C-terminus	NULL
of	NULL
this	NULL
transactivator	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Expression	NULL
Vectors	NULL
and	NULL
Reporter	NULL
Plasmids	NULL
All	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
amino	NULL
acids	NULL
1-461	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
IxB/MAD-3	NULL
(	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
cDNAs	NULL
were	NULL
subcloned	NULL
within	NULL
the	NULL
polylinker	NULL
sequences	NULL
of	NULL
the	NULL
pCMV4	NULL
expression	NULL
vector	NULL
(	NULL
Andersson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
downstream	NULL
of	NULL
the	NULL
cytomegalovirus	NULL
immediate	NULL
early	NULL
promoter	NULL
.	NULL

Carboxy-	NULL
and	NULL
amino-terminal	NULL
deletion	NULL
mutants	NULL
were	NULL
amplified	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
from	NULL
a	NULL
template	NULL
corresponding	NULL
to	NULL
the	NULL
full-length	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
cDNA	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
primers	NULL
used	NULL
in	NULL
these	NULL
reactions	NULL
were	NULL
designed	NULL
to	NULL
incorporate	NULL
a	NULL
consensus	NULL
translational	NULL
initiation	NULL
sequence	NULL
(	NULL
Kozak	NULL
,	NULL
1987	NULL
)	NULL
,	NULL
an	NULL
in-frame	NULL
stop	NULL
codon	NULL
,	NULL
and	NULL
unique	NULL
restriction	NULL
sites	NULL
to	NULL
facilitate	NULL
directional	NULL
cloning	NULL
into	NULL
pCMV4	NULL
.	NULL

Specific	NULL
site-directed	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
cDNA	NULL
using	NULL
the	NULL
phosphorothioate	NULL
method	NULL
and	NULL
oligonu-	NULL
Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL
cleotide	NULL
primers	NULL
that	NULL
introduced	NULL
diagnostic	NULL
restriction	NULL
sites	NULL
(	NULL
Nakamaye	NULL
and	NULL
Eckstein	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

The	NULL
Tax	NULL
expression	NULL
vector	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Rimsky	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Reporter	NULL
plasmids	NULL
contained	NULL
either	NULL
the	NULL
full-length	NULL
type	NULL
1	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV-1	NULL
)	NULL
LTR	NULL
(	NULL
Sodroski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
or	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
cassette	NULL
linked	NULL
to	NULL
a	NULL
heterologous	NULL
TATA	NULL
box	NULL
(	NULL
Stein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
,	NULL
cloned	NULL
immediately	NULL
upstream	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
reporter	NULL
gene	NULL
.	NULL

COS	NULL
Cell	NULL
Transfections	NULL
and	NULL
Extract	NULL
Preparations	NULL
The	NULL
COS	NULL
monkey	NULL
kidney	NULL
cell	NULL
line	NULL
was	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

One	NULL
day	NULL
before	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
seeded	NULL
in	NULL
0.1	NULL
%	NULL
gelatin-treated	NULL
six-well	NULL
plates	NULL
(	NULL
3	NULL
X	NULL
10°	NULL
cells/well	NULL
)	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
transfected	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
Holbrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
adherent	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
0.5	NULL
ml	NULL
of	NULL
DNA	NULL
cocktail	NULL
(	NULL
0.5	NULL
mg/ml	NULL
DEAE-dextran	NULL
and	NULL
2.5	NULL
ug/ml	NULL
plasmid	NULL
DNA	NULL
in	NULL
PBS	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
4.5	NULL
ml	NULL
of	NULL
Iscoves	NULL
medium	NULL
containing	NULL
100	NULL
aM	NULL
chlo-roquine	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
2.5	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
medium	NULL
was	NULL
aspirated	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
%	NULL
di-methyl	NULL
sulfoxide	NULL
for	NULL
2.5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

At	NULL
48-60	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
some	NULL
cells	NULL
were	NULL
starved	NULL
for	NULL
1	NULL
h	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
medium	NULL
lacking	NULL
cysteine	NULL
and	NULL
methionine	NULL
and	NULL
then	NULL
radiolabeled	NULL
for	NULL
2	NULL
h	NULL
with	NULL
and	NULL
[	NULL
*SJmethionine	NULL
(	NULL
150	NULL
each	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
under	NULL
low-stringency	NULL
conditions	NULL
by	NULL
lysis	NULL
with	NULL
ELB	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
]	NULL
,	NULL
pH	NULL
7.0	NULL
,	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
1.0	NULL
mM	NULL
phenyl-fluoride	NULL
)	NULL
supplemented	NULL
with	NULL
a	NULL
previously	NULL
described	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
(	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

After	NULL
a	NULL
10-min	NULL
incubation	NULL
at	NULL
4°C	NULL
,	NULL
lysed	NULL
cells	NULL
were	NULL
centrifuged	NULL
at	NULL
37	NULL
000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Clarified	NULL
supernatants	NULL
were	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
until	NULL
used	NULL
.	NULL

DNA	NULL
Binding	NULL
Studies	NULL
``	NULL
P-radiolabeled	NULL
kB	NULL
DNA	NULL
probes	NULL
were	NULL
prepared	NULL
by	NULL
annealing	NULL
a	NULL
27-base	NULL
coding	NULL
strand	NULL
template	NULL
(	NULL
5-CAACGGCAGGGGAATTCCC-CTCTCCTT-3	NULL
'	NULL
,	NULL
«	NULL
B-pd	NULL
)	NULL
to	NULL
a	NULL
complementary	NULL
10-base	NULL
primer	NULL
(	NULL
5'-AAG-GAGAGGG-3	NULL
'	NULL
)	NULL
and	NULL
filling	NULL
in	NULL
the	NULL
resultant	NULL
overhang	NULL
using	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
a-*	NULL
``	NULL
``	NULL
P	NULL
]	NULL
JdATP	NULL
,	NULL
[	NULL
«	NULL
-	NULL
``	NULL
P	NULL
]	NULL
dCTP	NULL
,	NULL
dGTP	NULL
,	NULL
and	NULL
dTTP	NULL
(	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
reactions	NULL
(	NULL
20	NULL
ul	NULL
)	NULL
contained	NULL
4	NULL
al	NULL
of	NULL
COS	NULL
cell	NULL
extract	NULL
(	NULL
~0.5	NULL
mg/ml	NULL
)	NULL
and	NULL
0.2	NULL
ug	NULL
of	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
buffered	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mg/ml	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
5	NULL
mM	NULL
DTT	NULL
(	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Approximately	NULL
10	NULL
fmol	NULL
of	NULL
P-labeled	NULL
probe	NULL
(	NULL
200	NULL
000	NULL
cpm	NULL
)	NULL
was	NULL
used	NULL
per	NULL
reaction	NULL
.	NULL

After	NULL
incubating	NULL
the	NULL
reactions	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
25	NULL
min	NULL
,	NULL
the	NULL
resultant	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
Bohnlein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
Analysis	NULL
Rabbit	NULL
antisera	NULL
were	NULL
prepared	NULL
(	NULL
Immunodynamics	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
against	NULL
carrier-conjugated	NULL
peptides	NULL
corresponding	NULL
to	NULL
unique	NULL
terminal	NULL
sequences	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
and	NULL
amino	NULL
acids	NULL
535-551	NULL
)	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
)	NULL
(	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
IxB/MAD-3	NULL
(	NULL
amino	NULL
acids	NULL
1-29	NULL
)	NULL
(	NULL
Haskill	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
studies	NULL
,	NULL
1	NULL
Ll	NULL
of	NULL
the	NULL
appropriate	NULL
antipeptide	NULL
antiserum	NULL
was	NULL
mixed	NULL
with	NULL
100	NULL
ul	NULL
of	NULL
precleared	NULL
``	NULL
S-labeled	NULL
COS	NULL
extract	NULL
and	NULL
400	NULL
Ll	NULL
of	NULL
ELB	NULL
buffer	NULL
.	NULL

Antibody	NULL
binding	NULL
reactions	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
and	NULL
then	NULL
supplemented	NULL
with	NULL
10	NULL
ul	NULL
(	NULL
packed	NULL
volume	NULL
)	NULL
of	NULL
protein	NULL
A-agarose	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
.	NULL

Solid-phase	NULL
immune	NULL
complexes	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
500	NULL
ul	NULL
of	NULL
ice-cold	NULL
ELB	NULL
buffer	NULL
,	NULL
boiled	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
,	NULL
5	NULL
%	NULL
B-mercaptoethanol	NULL
,	NULL
8	NULL
M	NULL
urea	NULL
,	NULL
and	NULL
fractionated	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

Radiolabeled	NULL
polypeptides	NULL
were	NULL
vi-	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
December	NULL
1992	NULL
Interactions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
IxB/MAD-3	NULL
sualized	NULL
by	NULL
fluorography	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Amplify	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
Protein	NULL
samples	NULL
(	NULL
~3.5	NULL
ug	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
8.75	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
followed	NULL
by	NULL
electrotransfer	NULL
onto	NULL
nitrocellulose	NULL
membranes	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
in	NULL
5	NULL
%	NULL
dry	NULL
milk	NULL
in	NULL
PBS/0.1	NULL
%	NULL
Tween	NULL
20	NULL
to	NULL
inhibit	NULL
nonspecific	NULL
protein	NULL
binding	NULL
and	NULL
then	NULL
sequentially	NULL
incubated	NULL
with	NULL
an	NULL
appropriate	NULL
dilution	NULL
of	NULL
specific	NULL
rabbit	NULL
antiserum	NULL
(	NULL
1	NULL
h	NULL
)	NULL
and	NULL
horseradish	NULL
peroxidase-conjugated	NULL
donkey	NULL
anti-rabbit	NULL
Ig	NULL
(	NULL
Amersham	NULL
;	NULL
1:2500	NULL
dilution	NULL
in	NULL
PBS/0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
washed	NULL
extensively	NULL
with	NULL
PBST	NULL
after	NULL
each	NULL
of	NULL
the	NULL
incubation	NULL
steps	NULL
.	NULL

Specific	NULL
immune	NULL
complexes	NULL
were	NULL
detected	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
ECL	NULL
Western	NULL
Blotting	NULL
Kit	NULL
;	NULL
Amer-sham	NULL
)	NULL
.	NULL

Indirect	NULL
Immunofluorescence	NULL
COS	NULL
cells	NULL
were	NULL
seeded	NULL
on	NULL
four-well	NULL
chamber	NULL
slides	NULL
(	NULL
Nunc	NULL
,	NULL
Naperville	NULL
,	NULL
IL	NULL
)	NULL
and	NULL
transfected	NULL
using	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
rinsed	NULL
once	NULL
with	NULL
PBS	NULL
and	NULL
fixed	NULL
for	NULL
20	NULL
min	NULL
in	NULL
3	NULL
%	NULL
parafor-maldehyde/10	NULL
%	NULL
FCS	NULL
in	NULL
PBS	NULL
.	NULL

After	NULL
rinsing	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
primary	NULL
rabbit	NULL
antiserum	NULL
(	NULL
diluted	NULL
in	NULL
PBS/	NULL
10	NULL
%	NULL
FCS	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
followed	NULL
by	NULL
three	NULL
5-min	NULL
washes	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
the	NULL
Texas	NULL
red-conjugated	NULL
donkey	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Amersham	NULL
;	NULL
1:500	NULL
dilution	NULL
in	NULL
PBS/10	NULL
%	NULL
FCS	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
four	NULL
times	NULL
in	NULL
PBS	NULL
,	NULL
the	NULL
slides	NULL
were	NULL
mounted	NULL
in	NULL
Gel/Mount	NULL
(	NULL
Biomeda	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
photographed	NULL
using	NULL
an	NULL
immunofluorescent	NULL
microscope	NULL
(	NULL
Diaplan	NULL
;	NULL
Leitz	NULL
,	NULL
Wetzlar	NULL
,	NULL
W.	NULL
Germany	NULL
)	NULL
.	NULL

Jurkat	NULL
T-Cell	NULL
Transfections	NULL
and	NULL
CAT	NULL
Assays	NULL
The	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
,	NULL
was	NULL
maintained	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
introduced	NULL
into	NULL
cells	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
Holbrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
250	NULL
Ll	NULL
of	NULL
a	NULL
0.5	NULL
mg/ml	NULL
DEAE-dextran	NULL
solution	NULL
containing	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Sub-sequently	NULL
,	NULL
5	NULL
ml	NULL
of	NULL
RPMI	NULL
containing	NULL
100	NULL
aM	NULL
chloroquine	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
continued	NULL
for	NULL
another	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
recovery	NULL
(	NULL
Bradford	NULL
,	NULL
1976	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
48	NULL
h	NULL
posttransfection	NULL
using	NULL
the	NULL
diffusion-based	NULL
liquid	NULL
scintillation	NULL
counting	NULL
method	NULL
described	NULL
by	NULL
Neumann	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

RESULTS	NULL
NF-	NULL
«	NULL
B	NULL
p65-Mediated	NULL
Activation	NULL
of	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
Enhancer	NULL
in	NULL
Human	NULL
T	NULL
Lymphocytes	NULL
is	NULL
Inhibited	NULL
by	NULL
IxB/MAD-3	NULL
Biochemical	NULL
reconstitution	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65/p50	NULL
heterodimer	NULL
is	NULL
functionally	NULL
sequestered	NULL
as	NULL
a	NULL
latent	NULL
complex	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
resting	NULL
T	NULL
lymphocytes	NULL
via	NULL
specific	NULL
protein-protein	NULL
interactions	NULL
between	NULL
IxB	NULL
and	NULL
as	NULL
yet	NULL
undefined	NULL
sequences	NULL
within	NULL
the	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Molitor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
in	NULL
vitro	NULL
assays	NULL
,	NULL
the	NULL
cytoplasmic	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
likely	NULL
released	NULL
from	NULL
IxB	NULL
after	NULL
phosphorylation	NULL
of	NULL
the	NULL
inhibitor	NULL
,	NULL
thereby	NULL
allowing	NULL
the	NULL
rapid	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
to	NULL
its	NULL
nuclear	NULL
site	NULL
of	NULL
action	NULL
(	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
;	NULL
Kerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
have	NULL
isolated	NULL
a	NULL
human	NULL
cDNA	NULL
clone	NULL
(	NULL
IxB/MAD-3	NULL
)	NULL
encoding	NULL
a	NULL
34-	NULL
to	NULL
37-kDa	NULL
polypeptide	NULL
that	NULL
inhibits	NULL
1341	NULL
P.A	NULL
.	NULL

Ganchi	NULL
et	NULL
al	NULL
.	NULL

A	NULL
PKA	NULL
NLS	NULL
(	NULL
RRPS	NULL
)	NULL
_	NULL
(	NULL
KRKR	NULL
)	NULL
MLZ	NULL
Rel	NULL
Homology	NULL
Domain	NULL
COOH	NULL
T	NULL
T	NULL
T	NULL
T	NULL
TOT	NULL
1	NULL
20	NULL
50	NULL
100	NULL
150	NULL
200	NULL
288	NULL
312	NULL
4114	NULL
450	NULL
500	NULL
551	NULL
$	NULL
o	NULL
C	NULL
97.4	NULL
-	NULL
25	NULL
xB-TATA	NULL
HTLV	NULL
LTR	NULL
CAT	NULL
CAT	NULL
l	NULL
1	NULL
F	NULL
--	NULL
1	NULL
20|-68.0	NULL
-	NULL
«	NULL
#	NULL
<	NULL
@	NULL
C	NULL
f	NULL
.0	NULL
C	NULL
g	NULL
15	NULL
C	NULL
»	NULL
g	NULL
43.0	NULL
-	NULL
=	NULL
10	NULL
O	NULL
L	NULL
«	NULL
&	NULL
®	NULL
5	NULL
32s	NULL
ss	NULL
u	NULL
,	NULL
bz	NULL
``	NULL
o	NULL
4	NULL
G4	NULL
4	NULL
G4	NULL
.	NULL

4	NULL
.	NULL

%	NULL
F3	NULL
*	NULL
4	NULL
p	NULL
p	NULL
p	NULL
tp	NULL
5	NULL
CD	NULL
Ty	NULL
Ta	NULL
To	NULL
Co	NULL
4	NULL
*	NULL
47	NULL
cab	NULL
)	NULL
“	NULL
a	NULL
X99	NULL
19g	NULL
09	NULL
6	NULL
‘	NULL
0/	NULL
79	NULL
I	NULL
?	NULL
)	NULL

o	NULL
Figure	NULL
1	NULL
.	NULL

The	NULL
transactivation	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
regulated	NULL
by	NULL
IxB/MAD-3	NULL
in	NULL
vivo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Primary	NULL
domain	NULL
structure	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

The	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
(	NULL
shaded	NULL
)	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
highly	NULL
conserved	NULL
motifs	NULL
,	NULL
a	NULL
basic	NULL
tetrapeptide	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
NLS/KRKR	NULL
)	NULL
,	NULL
and	NULL
a	NULL
protein	NULL
kinase	NULL
A	NULL
phosphorylation	NULL
consensus	NULL
sequence	NULL
(	NULL
PKA/RRPS	NULL
)	NULL
,	NULL
is	NULL
shown	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
(	NULL
black	NULL
)	NULL
and	NULL
the	NULL
``	NULL
mini-leucine	NULL
zipper	NULL
``	NULL
motif	NULL
(	NULL
MLZ	NULL
;	NULL
hatched	NULL
)	NULL
.	NULL

The	NULL
endpoints	NULL
of	NULL
specific	NULL
N-	NULL
and	NULL
C-terminal	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
truncation	NULL
mutants	NULL
used	NULL
throughout	NULL
this	NULL
study	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
of	NULL
C-terminally	NULL
truncated	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutants	NULL
.	NULL

Monkey	NULL
COS	NULL
cells	NULL
were	NULL
transfected	NULL
using	NULL
DEAE-dextran	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
either	NULL
wild-type	NULL
IxB/MAD-3	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
or	NULL
C-terminal	NULL
truncation	NULL
mutants	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
containing	NULL
the	NULL
indicated	NULL
N-	NULL
and	NULL
C-terminal	NULL
endpoints	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
.	NULL

Recipient	NULL
cells	NULL
were	NULL
metabolically	NULL
labeled	NULL
with	NULL
[	NULL
*SJcysteine	NULL
at	NULL
48	NULL
h	NULL
posttransfection	NULL
,	NULL
and	NULL
the	NULL
corresponding	NULL
extracts	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
with	NULL
polyclonal	NULL
antipeptide	NULL
antiserum	NULL
specific	NULL
for	NULL
either	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
;	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
IxB/MAD-3	NULL
(	NULL
amino	NULL
acids	NULL
1-29	NULL
;	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
I	NULL
«	NULL
B/MAD-3	NULL
specifically	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
p65-dependent	NULL
transactivation	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
indicated	NULL
wild-type	NULL
and	NULL
truncated	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
expression	NULL
vectors	NULL
,	NULL
along	NULL
with	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-1	NULL
«	NULL
B	NULL
enhancer	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
C	NULL
)	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
®	NULL
)	NULL
of	NULL
an	NULL
I	NULL
«	NULL
B/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

In	NULL
control	NULL
transfections	NULL
(	NULL
right	NULL
)	NULL
,	NULL
Jurkat	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
HTLV-1	NULL
Tax	NULL
expression	NULL
vector	NULL
and	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
linked	NULL
to	NULL
the	NULL
full-length	NULL
HTLV-1	NULL
LTR	NULL
.	NULL

CAT	NULL
activities	NULL
were	NULL
measured	NULL
after	NULL
48	NULL
h	NULL
of	NULL
culture	NULL
and	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
relative	NULL
fold-induction	NULL
over	NULL
basal	NULL
levels	NULL
obtained	NULL
with	NULL
unmodified	NULL
pCMV4	NULL
expression	NULL
vector	NULL
alone	NULL
.	NULL

the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
predicted	NULL
primary	NULL
structure	NULL
of	NULL
this	NULL
human	NULL
inhibitor	NULL
protein	NULL
is	NULL
also	NULL
fully	NULL
consistent	NULL
with	NULL
the	NULL
partial	NULL
amino	NULL
acid	NULL
sequence	NULL
determined	NULL
for	NULL
purified	NULL
rabbit	NULL
I	NULL
«	NULL
B	NULL
(	NULL
Davis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
intracellular	NULL
biologic	NULL
effects	NULL
of	NULL
IxB/	NULL
MAD-3	NULL
on	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
remain	NULL
unexamined	NULL
.	NULL

Transient	NULL
transfection	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
but	NULL
not	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
contains	NULL
unique	NULL
C-terminal	NULL
sequences	NULL
(	NULL
amino	NULL
acids	NULL
451-551	NULL
)	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
that	NULL
are	NULL
critical	NULL
for	NULL
activation	NULL
of	NULL
«	NULL
B-directed	NULL
transcription	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
IxB/MAD-3	NULL
specifically	NULL
regulates	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
in	NULL
vivo	NULL
,	NULL
a	NULL
series	NULL
of	NULL
C-terminally	NULL
truncated	NULL
cDNAs	NULL
were	NULL
constructed	NULL
that	NULL
encode	NULL
stable	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
variants	NULL
lacking	NULL
progressively	NULL
larger	NULL
portions	NULL
of	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Jurkat	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
cotransfected	NULL
with	NULL
recombinant	NULL
expression	NULL
1342	NULL
vectors	NULL
containing	NULL
these	NULL
truncated	NULL
cDNAs	NULL
and	NULL
an	NULL
HIV-1	NULL
«	NULL
B-CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
the	NULL
37-kDa	NULL
human	NULL
I	NULL
«	NULL
B/MAD-3	NULL
protein	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1C	NULL
,	NULL
coexpression	NULL
of	NULL
«	NULL
B-TATA-CAT	NULL
with	NULL
full-length	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
p65	NULL
WT	NULL
)	NULL
potently	NULL
stimulated	NULL
«	NULL
B-directed	NULL
transcription	NULL
(	NULL
~15-fold	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
levels	NULL
observed	NULL
with	NULL
unmodified	NULL
pCMV4	NULL
expression	NULL
vector	NULL
.	NULL

As	NULL
expected	NULL
(	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
C-terminal	NULL
101	NULL
amino	NULL
acids	NULL
(	NULL
amino	NULL
acids	NULL
451-551	NULL
)	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
disrupted	NULL
the	NULL
transcriptional	NULL
activity	NULL
observed	NULL
with	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
protein	NULL
.	NULL

More	NULL
im-portantly	NULL
,	NULL
coexpression	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
with	NULL
functionally	NULL
active	NULL
members	NULL
of	NULL
this	NULL
deletion	NULL
series	NULL
completely	NULL
abolished	NULL
NF-	NULL
«	NULL
B	NULL
p65-mediated	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
specific	NULL
deletion	NULL
of	NULL
a	NULL
'	NULL
``	NULL
mini-leucine	NULL
zipper	NULL
``	NULL
motif	NULL
located	NULL
immediately	NULL
adjacent	NULL
to	NULL
the	NULL
primary	NULL
transactivation	NULL
domain	NULL
(	NULL
see	NULL
Figure	NULL
1A	NULL
)	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
activity	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
,	NULL
did	NULL
not	NULL
sig-	NULL
Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL
nificantly	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
IxB/MAD-3	NULL
to	NULL
inhibit	NULL
NF-kB	NULL
p65-induced	NULL
transcription	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IxB/MAD-3	NULL
failed	NULL
to	NULL
significantly	NULL
block	NULL
Tax-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
,	NULL
a	NULL
response	NULL
that	NULL
proceeds	NULL
independently	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factor	NULL
pathway	NULL
(	NULL
Paskalis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Shimo-tohno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
;	NULL
Brady	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Smith	NULL
and	NULL
Greene	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
thus	NULL
demonstrate	NULL
that	NULL
IxB/MAD-3	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
in	NULL
vivo	NULL
,	NULL
presumably	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
the	NULL
proposed	NULL
ability	NULL
of	NULL
IxB/MAD-3	NULL
to	NULL
retain	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

IxB/MAD-3	NULL
Regulates	NULL
the	NULL
Nuclear	NULL
Expression	NULL
of	NULL
Both	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
but	NULL
Blocks	NULL
the	NULL
DNA	NULL
Binding	NULL
Activity	NULL
of	NULL
Only	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
The	NULL
previous	NULL
finding	NULL
that	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
involved	NULL
in	NULL
its	NULL
interaction	NULL
with	NULL
IxB	NULL
(	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
homologous	NULL
sequences	NULL
present	NULL
in	NULL
the	NULL
N-terminal	NULL
half	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
might	NULL
also	NULL
interact	NULL
with	NULL
I	NULL
«	NULL
xB	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
relative	NULL
effects	NULL
of	NULL
IxB/MAD-3	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
overexpressing	NULL
each	NULL
of	NULL
these	NULL
subunits	NULL
,	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
IxB/MAD-3	NULL
,	NULL
were	NULL
tested	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
a	NULL
*P-labeled	NULL
kB	NULL
enhancer	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2A	NULL
,	NULL
in	NULL
vivo	NULL
synthesized	NULL
forms	NULL
of	NULL
both	NULL
subunits	NULL
bound	NULL
to	NULL
this	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
I	NULL
«	NULL
xB/MAD-3	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
distinct	NULL
nucleoprotein	NULL
complexes	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Whereas	NULL
coexpression	NULL
of	NULL
IxB/MAD-3	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
completely	NULL
blocked	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
coexpression	NULL
of	NULL
IxB/MAD-3	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
failed	NULL
to	NULL
inhibit	NULL
the	NULL
formation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50/	NULL
«	NULL
B	NULL
enhancer	NULL
complexes	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
in	NULL
vivo	NULL
data	NULL
are	NULL
thus	NULL
fully	NULL
consistent	NULL
with	NULL
previous	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
studies	NULL
performed	NULL
using	NULL
in	NULL
vitro	NULL
synthesized	NULL
proteins	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Zabel	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
contains	NULL
sequences	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
that	NULL
are	NULL
not	NULL
found	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

However	NULL
,	NULL
these	NULL
findings	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
I	NULL
«	NULL
B/MAD-3	NULL
binds	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
even	NULL
though	NULL
it	NULL
fails	NULL
to	NULL
block	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

To	NULL
directly	NULL
compare	NULL
the	NULL
relative	NULL
IxB/MAD-3	NULL
binding	NULL
capacities	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
coimmunoprecipitation	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
subunit-specific	NULL
antipeptide	NULL
antisera	NULL
using	NULL
*°S-labeled	NULL
extracts	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
2B	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65-specific	NULL
antiserum	NULL
immunoprecipitated	NULL
a	NULL
major	NULL
65-	NULL
to	NULL
72-kDa	NULL
polypeptide	NULL
in	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
expression	NULL
vector	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Coexpression	NULL
of	NULL
IxB/MAD-3	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
in	NULL
these	NULL
recipient	NULL
cells	NULL
resulted	NULL
in	NULL
the	NULL
detection	NULL
of	NULL
a	NULL
second	NULL
major	NULL
polypeptide	NULL
of	NULL
35-40	NULL
kDa	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
which	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
molecular	NULL
weight	NULL
reported	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
December	NULL
1992	NULL
Interactions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
I	NULL
«	NULL
B/MAD-3	NULL
A	NULL
p65	NULL
p50	NULL
B	NULL
p65	NULL
p50	NULL
M	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
<	NULL
stp	NULL
ame	NULL
@	NULL
®	NULL
five	NULL
IxB	NULL
:	NULL
-	NULL
+	NULL
-	NULL
+	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
I	NULL
«	NULL
B/MAD-3	NULL
regulates	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
in	NULL
vivo	NULL
.	NULL

{	NULL
(	NULL
A	NULL
)	NULL
I	NULL
«	NULL
B/MAD-3	NULL
selectively	NULL
inhibits	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
but	NULL
not	NULL
that	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
cDNA	NULL
expression	NULL
vectors	NULL
encoding	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
of	NULL
an	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
recipient	NULL
cell	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
gel	NULL
retardation	NULL
assay	NULL
using	NULL
a	NULL
**P-radiolabeled	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

(	NULL
B	NULL
)	NULL
I	NULL
«	NULL
B/MAD-3	NULL
forms	NULL
a	NULL
stable	NULL
complex	NULL
with	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

S-labeled	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
either	NULL
alone	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
with	NULL
subunit-specific	NULL
antisera	NULL
.	NULL

Immunoreactive	NULL
complexes	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
detected	NULL
by	NULL
fluorography	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Assembly	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
prevents	NULL
the	NULL
nuclear	NULL
import	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
a	NULL
and	NULL
b	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
c	NULL
and	NULL
d	NULL
)	NULL
of	NULL
an	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
fixed	NULL
,	NULL
treated	NULL
with	NULL
rabbit	NULL
antiserum	NULL
specific	NULL
for	NULL
each	NULL
subunit	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
indirect	NULL
immunofluorescence	NULL
staining	NULL
using	NULL
Texas	NULL
red-conjugated	NULL
anti-rabbit	NULL
Ig	NULL
.	NULL

1343	NULL
P.A	NULL
.	NULL

Ganchi	NULL
et	NULL
al	NULL
.	NULL

A	NULL
_	NULL
4	NULL
za	NULL
s	NULL
a	NULL
soe	NULL
to	NULL
so	NULL
oo	NULL
C	NULL
Aull	NULL
y	NULL
1	NULL
i	NULL
1	NULL
1	NULL
1	NULL
a	NULL
1	NULL
2	NULL
3	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
.	NULL

I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
..	NULL
97.4	NULL
-IxB	NULL
68.0	NULL
~~~	NULL
Ce	NULL
@	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
.	NULL

I	NULL
I	NULL
B	NULL
43.0	NULL
#	NULL
IxB	NULL
»	NULL
+IxB	NULL
«	NULL
s	NULL
*	NULL
bee	NULL
29.0	NULL
KK	NULL
Co	NULL
L	NULL
e	NULL
to	NULL
X	NULL
4	NULL
&	NULL
§	NULL
’	NULL
¢	NULL
)	NULL
°3	NULL
’	NULL
%	NULL
%	NULL
00	NULL
%	NULL
0	NULL
%	NULL
®	NULL
%	NULL
3	NULL
%	NULL
*	NULL
>	NULL
4	NULL
43	NULL
%	NULL
**	NULL
*	NULL
%	NULL
*	NULL
%	NULL
%	NULL
*	NULL
Figure	NULL
3	NULL
.	NULL

The	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
and	NULL
the	NULL
unique	NULL
C-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
mediate	NULL
a	NULL
fully	NULL
functional	NULL
interaction	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
The	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
.	NULL

Monkey	NULL
COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
pCMV4	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
C-terminal	NULL
truncation	NULL
mutants	NULL
(	NULL
lanes	NULL
3-9	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
A	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
B	NULL
)	NULL
of	NULL
an	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Control	NULL
transfections	NULL
performed	NULL
with	NULL
unmodified	NULL
vector	NULL
(	NULL
pCMV4	NULL
)	NULL
and	NULL
full-length	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
p65	NULL
WT	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
.	NULL

Extracts	NULL
from	NULL
recipient	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
P-labeled	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
C-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
dispensible	NULL
for	NULL
I	NULL
«	NULL
B/MAD-3	NULL
binding	NULL
.	NULL

S-labeled	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
either	NULL
unmodified	NULL
pCMV4	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
I	NULL
«	NULL
B/MAD-3	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
the	NULL
indicated	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
constructs	NULL
in	NULL
combination	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
(	NULL
lanes	NULL
4-10	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
p65-specific	NULL
antipeptide	NULL
antiserum	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
)	NULL
.	NULL

Radiolabeled	NULL
immune	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
detected	NULL
by	NULL
fluorography	NULL
.	NULL

The	NULL
relative	NULL
positions	NULL
and	NULL
sizes	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
of	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
given	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
arrow	NULL
identifies	NULL
the	NULL
position	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

for	NULL
human	NULL
IxB/MAD-3	NULL
(	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

This	NULL
protein	NULL
was	NULL
also	NULL
readily	NULL
detected	NULL
with	NULL
anti-MAD-3	NULL
antiserum	NULL
(	NULL
Ganchi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

In	NULL
reciprocal	NULL
antibody	NULL
binding	NULL
studies	NULL
with	NULL
extracts	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
p50-transfected	NULL
COS	NULL
cells	NULL
,	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50-specific	NULL
antiserum	NULL
immunoprecipitated	NULL
a	NULL
48-	NULL
to	NULL
55-kDa	NULL
polypeptide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
predicted	NULL
size	NULL
of	NULL
this	NULL
Rel-related	NULL
subunit	NULL
.	NULL

Surprisingly	NULL
,	NULL
despite	NULL
the	NULL
inability	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
to	NULL
block	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
IxB/MAD-3	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
immunoprecipitates	NULL
from	NULL
COS	NULL
cells	NULL
coexpressing	NULL
these	NULL
polypeptides	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
thus	NULL
demonstrate	NULL
the	NULL
unexpected	NULL
capacity	NULL
of	NULL
IxB/MAD-3	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
to	NULL
form	NULL
stable	NULL
complexes	NULL
in	NULL
vivo	NULL
.	NULL

Studies	NULL
were	NULL
next	NULL
performed	NULL
to	NULL
examine	NULL
whether	NULL
IxB/	NULL
MAD-3	NULL
modulated	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

Immunofluorescent	NULL
staining	NULL
of	NULL
COS	NULL
cells	NULL
expressing	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
with	NULL
specific	NULL
anti-NF-	NULL
«	NULL
B	NULL
p65	NULL
antiserum	NULL
revealed	NULL
a	NULL
diffuse	NULL
,	NULL
predominantly	NULL
perinuclear	NULL
,	NULL
or	NULL
whole-cell	NULL
pattern	NULL
of	NULL
fluorescence	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
a	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
coexpression	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
yielded	NULL
a	NULL
nuclear-excluded	NULL
distribution	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
c	NULL
)	NULL
.	NULL

When	NULL
NF-	NULL
«	NULL
B	NULL
p50-expressing	NULL
COS	NULL
cells	NULL
were	NULL
probed	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
p50-specific	NULL
antiserum	NULL
,	NULL
a	NULL
primarily	NULL
nuclear	NULL
pattern	NULL
of	NULL
expression	NULL
was	NULL
1344	NULL
observed	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
b	NULL
)	NULL
.	NULL

However	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
to	NULL
engage	NULL
Ix	NULL
«	NULL
B/MAD-3	NULL
,	NULL
this	NULL
immunoreactive	NULL
species	NULL
was	NULL
completely	NULL
retargeted	NULL
to	NULL
the	NULL
cytoplasm	NULL
after	NULL
coexpression	NULL
with	NULL
IxB/MAD-3	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
d	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
I	NULL
«	NULL
B/MAD-3	NULL
is	NULL
capable	NULL
of	NULL
regulating	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
the	NULL
homodimeric	NULL
forms	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

The	NULL
Transactivation	NULL
Domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
Selectively	NULL
Required	NULL
for	NULL
IxB-Mediated	NULL
Inhibition	NULL
of	NULL
DNA	NULL
Binding	NULL
but	NULL
not	NULL
for	NULL
IxB/MAD-3	NULL
Binding	NULL
To	NULL
determine	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
sequences	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
the	NULL
C-terminal	NULL
deletion	NULL
series	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutants	NULL
were	NULL
examined	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
,	NULL
inhibition	NULL
of	NULL
binding	NULL
by	NULL
IxB/MAD-3	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
,	NULL
and	NULL
stable	NULL
association	NULL
with	NULL
IxB/MAD-3	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
after	NULL
transfection	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

In	NULL
gel	NULL
retardation	NULL
assays	NULL
,	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
cDNA	NULL
supported	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
single	NULL
nucleoprotein	NULL
complex	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
that	NULL
was	NULL
absent	NULL
in	NULL
DNA-binding	NULL
reactions	NULL
performed	NULL
using	NULL
control	NULL
extracts	NULL
prepared	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
parental	NULL
pCMV4	NULL
expression	NULL
vector	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
unique	NULL
C-terminal	NULL
Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL
non-Rel	NULL
sequences	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
which	NULL
encompass	NULL
the	NULL
principal	NULL
transactivation	NULL
domain	NULL
(	NULL
see	NULL
Figure	NULL
1A	NULL
)	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
modestly	NULL
enhanced	NULL
the	NULL
overall	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Figure	NULL
3	NULL
,	NULL
lanes	NULL
5-8	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
earlier	NULL
observations	NULL
of	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
C-terminal	NULL
sequences	NULL
intrinsically	NULL
attenuate	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

Deletion	NULL
to	NULL
amino	NULL
acid	NULL
291	NULL
,	NULL
which	NULL
removes	NULL
a	NULL
basic	NULL
stretch	NULL
of	NULL
residues	NULL
(	NULL
KRKR	NULL
;	NULL
amino	NULL
acids	NULL
301-304	NULL
;	NULL
see	NULL
Figure	NULL
1A	NULL
)	NULL
resembling	NULL
the	NULL
functional	NULL
nuclear	NULL
localization	NULL
signal	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
also	NULL
had	NULL
no	NULL
negative	NULL
effect	NULL
on	NULL
DNA	NULL
binding	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
removal	NULL
of	NULL
three	NULL
additional	NULL
amino	NULL
acids	NULL
to	NULL
residue	NULL
288	NULL
completely	NULL
disrupted	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
thus	NULL
mapping	NULL
the	NULL
C-terminal	NULL
boundary	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
domain	NULL
to	NULL
between	NULL
amino	NULL
acids	NULL
289	NULL
and	NULL
291	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

In	NULL
parallel	NULL
experiments	NULL
,	NULL
this	NULL
series	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
was	NULL
coexpressed	NULL
in	NULL
COS	NULL
cells	NULL
with	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
an	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Results	NULL
from	NULL
gel	NULL
retardation	NULL
studies	NULL
performed	NULL
with	NULL
extracts	NULL
from	NULL
these	NULL
cotransfected	NULL
cells	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
3B	NULL
.	NULL

Consistent	NULL
with	NULL
prior	NULL
in	NULL
vitro	NULL
reconstitution	NULL
studies	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
coexpression	NULL
of	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
in	NULL
vivo	NULL
completely	NULL
blocked	NULL
«	NULL
B	NULL
enhancer	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Similar	NULL
inhibitory	NULL
effects	NULL
were	NULL
observed	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutant	NULL
lacking	NULL
the	NULL
C-terminal	NULL
51	NULL
amino	NULL
acids	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
removal	NULL
of	NULL
all	NULL
of	NULL
the	NULL
primary	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transactivation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
451-551	NULL
;	NULL
see	NULL
Figure	NULL
1A	NULL
)	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
yielded	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutant	NULL
that	NULL
was	NULL
entirely	NULL
refractory	NULL
to	NULL
IxB-mediated	NULL
inhibition	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutants	NULL
terminated	NULL
between	NULL
amino	NULL
acids	NULL
291	NULL
and	NULL
312	NULL
(	NULL
lanes	NULL
5-8	NULL
)	NULL
retained	NULL
DNA	NULL
binding	NULL
activity	NULL
when	NULL
coexpressed	NULL
with	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
the	NULL
I	NULL
«	NULL
xB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Subsequent	NULL
titration	NULL
experiments	NULL
performed	NULL
with	NULL
the	NULL
latter	NULL
NF-	NULL
«	NULL
B	NULL
truncation	NULL
mutant	NULL
revealed	NULL
significant	NULL
inhibitory	NULL
effects	NULL
on	NULL
DNA	NULL
binding	NULL
activity	NULL
only	NULL
at	NULL
higher	NULL
(	NULL
at	NULL
least	NULL
4:1	NULL
vector	NULL
ratio	NULL
)	NULL
doses	NULL
of	NULL
IkB/MAD-3	NULL
(	NULL
Ganchi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

These	NULL
surprising	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
C-terminal	NULL
activation	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

The	NULL
precise	NULL
subregion	NULL
(	NULL
s	NULL
)	NULL
within	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
required	NULL
for	NULL
IxB/MAD-3	NULL
binding	NULL
in	NULL
vivo	NULL
remains	NULL
unknown	NULL
.	NULL

To	NULL
determine	NULL
these	NULL
requisite	NULL
sequences	NULL
,	NULL
COS	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
IxB/	NULL
MAD-3	NULL
and	NULL
each	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
C-terminal	NULL
deletion	NULL
mutants	NULL
.	NULL

These	NULL
cell	NULL
were	NULL
then	NULL
metabolically	NULL
radiolabeled	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
with	NULL
specific	NULL
antipeptide	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
N-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3C	NULL
,	NULL
this	NULL
antiserum	NULL
specifically	NULL
immunoprecipitated	NULL
a	NULL
65-	NULL
to	NULL
72-	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
December	NULL
1992	NULL
Interactions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
I	NULL
«	NULL
B/MAD-3	NULL
kDa	NULL
radiolabeled	NULL
polypeptide	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
expression	NULL
vector	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
encoding	NULL
I	NULL
«	NULL
B/MAD-3	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
lacking	NULL
a	NULL
cDNA	NULL
insert	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

When	NULL
the	NULL
IxB/MAD-3	NULL
cDNA	NULL
was	NULL
coexpressed	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
a	NULL
35-	NULL
to	NULL
40-kDa	NULL
radiolabeled	NULL
polypeptide	NULL
was	NULL
readily	NULL
coimmunoprecipitated	NULL
from	NULL
recipient	NULL
cell	NULL
extracts	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
formation	NULL
of	NULL
stable	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
/IxB	NULL
complexes	NULL
in	NULL
vivo	NULL
.	NULL

However	NULL
,	NULL
removal	NULL
of	NULL
the	NULL
C-terminal	NULL
activation	NULL
domain	NULL
sequences	NULL
,	NULL
which	NULL
were	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
I	NULL
«	NULL
B/	NULL
MAD-3	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Further	NULL
deletion	NULL
to	NULL
residue	NULL
312	NULL
was	NULL
also	NULL
without	NULL
effect	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
but	NULL
deletion	NULL
to	NULL
amino	NULL
acid	NULL
296	NULL
or	NULL
beyond	NULL
,	NULL
which	NULL
disrupts	NULL
the	NULL
putative	NULL
nuclear	NULL
localization	NULL
signal	NULL
,	NULL
yielded	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
variants	NULL
that	NULL
failed	NULL
to	NULL
complex	NULL
with	NULL
IxB/MAD-3	NULL
(	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

These	NULL
coimmunoprecipitation	NULL
studies	NULL
thus	NULL
establish	NULL
that	NULL
the	NULL
C-terminal	NULL
boundary	NULL
required	NULL
for	NULL
IxB/	NULL
MAD-3	NULL
binding	NULL
lies	NULL
between	NULL
amino	NULL
acids	NULL
297	NULL
and	NULL
312	NULL
,	NULL
which	NULL
is	NULL
different	NULL
from	NULL
the	NULL
C-terminal	NULL
boundary	NULL
for	NULL
DNA	NULL
binding	NULL
(	NULL
amino	NULL
acids	NULL
289-291	NULL
)	NULL
.	NULL

These	NULL
results	NULL
further	NULL
demonstrate	NULL
that	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
,	NULL
is	NULL
not	NULL
itself	NULL
an	NULL
essential	NULL
part	NULL
of	NULL
the	NULL
I	NULL
«	NULL
B/MAD-3	NULL
binding	NULL
site	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

The	NULL
Most	NULL
N-terminal	NULL
Residues	NULL
of	NULL
the	NULL
Rel	NULL
Homology	NULL
Domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
are	NULL
Required	NULL
for	NULL
DNA	NULL
Binding	NULL
but	NULL
not	NULL
for	NULL
Association	NULL
with	NULL
IxB/MAD-3	NULL
To	NULL
complement	NULL
these	NULL
C-terminal	NULL
deletion	NULL
mapping	NULL
studies	NULL
,	NULL
reciprocal	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
series	NULL
of	NULL
N-terminally	NULL
truncated	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutants	NULL
.	NULL

To	NULL
optimize	NULL
translation	NULL
,	NULL
each	NULL
of	NULL
these	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
cDNA	NULL
mutants	NULL
was	NULL
prepared	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
and	NULL
matched	NULL
5	NULL
'	NULL
oligonucleotide	NULL
primers	NULL
that	NULL
incorporated	NULL
a	NULL
consensus	NULL
translational	NULL
initiation	NULL
sequence	NULL
(	NULL
Kozak	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
prepared	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
these	NULL
mutant	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
constructs	NULL
were	NULL
subsequently	NULL
tested	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

In	NULL
control	NULL
reactions	NULL
,	NULL
a	NULL
single	NULL
specific	NULL
nucleoprotein	NULL
complex	NULL
was	NULL
detected	NULL
with	NULL
extracts	NULL
containing	NULL
full-length	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
with	NULL
extracts	NULL
from	NULL
mock-transfected	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

This	NULL
DNA	NULL
binding	NULL
activity	NULL
persisted	NULL
after	NULL
deletion	NULL
of	NULL
up	NULL
to	NULL
20	NULL
N-terminal	NULL
amino	NULL
acids	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
which	NULL
affects	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
sequences	NULL
that	NULL
are	NULL
divergent	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

However	NULL
,	NULL
removal	NULL
of	NULL
10	NULL
or	NULL
more	NULL
additional	NULL
residues	NULL
,	NULL
which	NULL
involves	NULL
the	NULL
proximal	NULL
boundary	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
completely	NULL
abolished	NULL
this	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
lanes	NULL
5-7	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
each	NULL
of	NULL
the	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
complexes	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
coexpression	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
IxB/MAD-3	NULL
(	NULL
Figure	NULL
4B	NULL
;	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
,	NULL
in	NULL
1345	NULL
P.A	NULL
.	NULL

Ganchi	NULL
et	NULL
al	NULL
.	NULL

1	NULL
7	NULL
Ao	NULL
j	NULL
$	NULL
$	NULL
f	NULL
f	NULL
9	NULL
i	NULL
C	NULL
97.4-1s	NULL
@	NULL
00	NULL
68.0	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
B	NULL
43.0	NULL
+1xB	NULL
29.0	NULL
Lo	NULL
Lo	NULL
LO	NULL
On	NULL
On	NULL
Am	NULL
A	NULL
6s	NULL
``	NULL
6s	NULL
©6626	NULL
,	NULL
*C	NULL
42	NULL
m	NULL
,	NULL
7	NULL
,	NULL
40	NULL
,	NULL
48	NULL
,	NULL
Ir	NULL
,	NULL
``	NULL
0	NULL
,	NULL
'	NULL
_C	NULL
'	NULL
e	NULL
*	NULL
3	NULL
4	NULL
%	NULL
P	NULL
D	NULL
4	NULL
4	NULL
V	NULL
-IxB	NULL
to	NULL
%	NULL
%	NULL
%	NULL
o	NULL
0	NULL
%	NULL
%	NULL
C	NULL
&	NULL
%	NULL
%	NULL
An	NULL
On	NULL
On	NULL
On	NULL
On	NULL
On	NULL
On	NULL
A	NULL
a	NULL
%	NULL
L	NULL
%	NULL
b	NULL
,	NULL
%	NULL
4	NULL
4	NULL
G	NULL
%	NULL
%	NULL
6	NULL
42	NULL
,	NULL
A	NULL
T	NULL
R	NULL
t	NULL
*t	NULL
t	NULL
To	NULL
's	NULL
¢	NULL
$	NULL
.	NULL

$	NULL
$	NULL
$	NULL
3	NULL
a	NULL
3	NULL
,	NULL
*s	NULL
9999969967	NULL
}	NULL
Figure	NULL
4	NULL
.	NULL

-	NULL
The	NULL
N-terminal	NULL
boundaries	NULL
of	NULL
both	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
IxB/MAD-3	NULL
binding	NULL
domain	NULL
are	NULL
distinct	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
The	NULL
most	NULL
N-terminal	NULL
sequences	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
are	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
expression	NULL
vectors	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
A	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
B	NULL
)	NULL
of	NULL
an	NULL
I	NULL
«	NULL
B/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Control	NULL
transfections	NULL
were	NULL
performed	NULL
with	NULL
unmodified	NULL
pCMV4	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
full-length	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
p65	NULL
WT	NULL
;	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Recipient	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
P-labeled	NULL
palindromic	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
N-terminal	NULL
half	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
dispensible	NULL
for	NULL
association	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

Extracts	NULL
from	NULL
COS	NULL
cells	NULL
coexpressing	NULL
IxB/MAD-3	NULL
together	NULL
with	NULL
the	NULL
parental	NULL
pCMV4	NULL
expression	NULL
vector	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
the	NULL
indicated	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
variants	NULL
(	NULL
lanes	NULL
2-10	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
an	NULL
antipeptide	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
C-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
535-551	NULL
)	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
subjected	NULL
to	NULL
reducing	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
and	NULL
visualized	NULL
by	NULL
fluorography	NULL
.	NULL

The	NULL
relative	NULL
positions	NULL
and	NULL
sizes	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
of	NULL
molecular	NULL
weight	NULL
standards	NULL
are	NULL
as	NULL
shown	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

contrast	NULL
to	NULL
the	NULL
C-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
virtually	NULL
the	NULL
entire	NULL
N-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
.	NULL

To	NULL
delineate	NULL
the	NULL
N-terminal	NULL
boundary	NULL
of	NULL
the	NULL
IxB/	NULL
MAD-3	NULL
binding	NULL
domain	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
a	NULL
more	NULL
extensive	NULL
series	NULL
of	NULL
N-terminal	NULL
truncation	NULL
mutants	NULL
was	NULL
cotransfected	NULL
into	NULL
COS	NULL
cells	NULL
with	NULL
equivalent	NULL
amounts	NULL
of	NULL
the	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Radiolabeled	NULL
extracts	NULL
from	NULL
these	NULL
cells	NULL
were	NULL
then	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
with	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4C	NULL
,	NULL
I	NULL
«	NULL
B/MAD-3	NULL
was	NULL
readily	NULL
immunoprecipitated	NULL
with	NULL
this	NULL
antiserum	NULL
when	NULL
coexpressed	NULL
with	NULL
the	NULL
full-length	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
protein	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
deletion	NULL
of	NULL
up	NULL
to	NULL
150	NULL
N-terminal	NULL
residues	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
stable	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
complex	NULL
(	NULL
lanes	NULL
3-9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
50	NULL
additional	NULL
N-terminal	NULL
amino	NULL
acids	NULL
completely	NULL
abolished	NULL
its	NULL
ability	NULL
to	NULL
engage	NULL
IkB/	NULL
MAD-3	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

These	NULL
deletion	NULL
mapping	NULL
results	NULL
thus	NULL
localize	NULL
the	NULL
N-terminal	NULL
boundary	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
receptor	NULL
domain	NULL
for	NULL
IxB/MAD-3	NULL
to	NULL
between	NULL
amino	NULL
acids	NULL
151	NULL
and	NULL
200	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
21-291	NULL
)	NULL
,	NULL
which	NULL
spans	NULL
virtually	NULL
the	NULL
entire	NULL
Rel	NULL
homology	NULL
region	NULL
,	NULL
the	NULL
Ix	NULL
«	NULL
B/MAD-3	NULL
binding	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
151-312	NULL
)	NULL
encompasses	NULL
only	NULL
the	NULL
distal	NULL
half	NULL
of	NULL
this	NULL
region	NULL
.	NULL

1346	NULL
The	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
a	NULL
Primary	NULL
Target	NULL
for	NULL
IxB/	NULL
MAD-3	NULL
Binding	NULL
Inspection	NULL
of	NULL
the	NULL
IxB/MAD-3	NULL
receptor	NULL
domain	NULL
within	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
was	NULL
remarkable	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
basic	NULL
subregion	NULL
(	NULL
KRKR	NULL
;	NULL
amino	NULL
acids	NULL
301-304	NULL
;	NULL
see	NULL
Figure	NULL
1A	NULL
)	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
that	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
functional	NULL
NLS	NULL
present	NULL
at	NULL
comparable	NULL
positions	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
RKRQK	NULL
;	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
v-Rel	NULL
(	NULL
KRQR	NULL
;	NULL
Gilmore	NULL
and	NULL
Temin	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
motif	NULL
in	NULL
I	NULL
«	NULL
B-mediated	NULL
inhibition	NULL
,	NULL
IxB/MAD-3	NULL
binding	NULL
,	NULL
and	NULL
nuclear	NULL
translo-cation	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
was	NULL
used	NULL
to	NULL
selectively	NULL
delete	NULL
these	NULL
four	NULL
codons	NULL
from	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
cDNA	NULL
.	NULL

Monkey	NULL
COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
resultant	NULL
cDNA	NULL
expression	NULL
vector	NULL
(	NULL
p65	NULL
ANLS	NULL
)	NULL
along	NULL
with	NULL
increasing	NULL
doses	NULL
of	NULL
the	NULL
human	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Extracts	NULL
from	NULL
these	NULL
COS	NULL
cell	NULL
transfectants	NULL
were	NULL
normalized	NULL
for	NULL
equivalent	NULL
protein	NULL
expression	NULL
and	NULL
subjected	NULL
to	NULL
gel	NULL
retardation	NULL
analysis	NULL
using	NULL
a	NULL
P-labeled	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
IxB/MAD-3	NULL
,	NULL
p65	NULL
ANLS	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
appeared	NULL
to	NULL
bind	NULL
DNA	NULL
with	NULL
increased	NULL
affinity	NULL
relative	NULL
to	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
protein	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
titration	NULL
with	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
sharply	NULL
attenuated	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL
Interactions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
I	NULL
«	NULL
B/MAD-3	NULL
+1xB	NULL
+IxB	NULL
+IxB	NULL
B	NULL
-	NULL
O4	NULL
-N	NULL
-t	NULL
-	NULL
»	NULL
-	NULL
&	NULL
n	NULL
-o	NULL
-~	NULL
-	NULL
co	NULL
-w	NULL
wk	NULL
o	NULL
-	NULL
wk	NULL
-n	NULL
-to	NULL
-	NULL
&	NULL
-	NULL
&	NULL
n	NULL
-o	NULL
-~	NULL
-	NULL
co	NULL
-w	NULL
Za	NULL
33	NULL
97.4	NULL
60.0	NULL
-a	NULL
<	NULL
»	NULL
apdibdi	NULL
am	NULL
-	NULL
»	NULL
-	NULL
<	NULL
p65	NULL
43.0	NULL
«	NULL
»	NULL
«	NULL
a	NULL
»	NULL
am	NULL
€Bb	NULL
-	NULL
<	NULL
~IxB	NULL
29.0	NULL
N	NULL
___	NULL
RL	NULL
N	NULL
r	NULL
roo	NULL
carers	NULL
cines	NULL
oR	NULL
p65	NULL
WT	NULL
p65	NULL
ANLS	NULL
p65	NULL
WT	NULL
-	NULL
p65	NULL
ANLS	NULL
Figure	NULL
5	NULL
.	NULL

The	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
IxB/MAD-3	NULL
function	NULL
.	NULL

(	NULL
A	NULL
)	NULL
I	NULL
«	NULL
B/MAD-3	NULL
fails	NULL
to	NULL
inhibit	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
variant	NULL
lacking	NULL
the	NULL
highly	NULL
conserved	NULL
NLS	NULL
.	NULL

Monkey	NULL
COS	NULL
cell	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
encoding	NULL
either	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
lanes	NULL
1-5	NULL
)	NULL
or	NULL
p65	NULL
ANLS	NULL
(	NULL
lanes	NULL
6-10	NULL
)	NULL
,	NULL
along	NULL
with	NULL
increasing	NULL
doses	NULL
(	NULL
mock	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
;	NULL
0.25	NULL
ug	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
7	NULL
;	NULL
0.5	NULL
ug	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
8	NULL
;	NULL
1.0	NULL
ug	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
9	NULL
;	NULL
2.0	NULL
ug	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
10	NULL
)	NULL
of	NULL
an	NULL
IxB/MAD-3	NULL
expression	NULL
vector	NULL
.	NULL

Recipient	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
``	NULL
P-labeled	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
/	NULL
«	NULL
B	NULL
enhancer	NULL
complexes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Deletion	NULL
of	NULL
the	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
disrupts	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
described	NULL
in	NULL
A	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
p65-specific	NULL
antipeptide	NULL
antiserum	NULL
(	NULL
amino	NULL
acids	NULL
535-551	NULL
)	NULL
.	NULL

Radiolabeled	NULL
immunoprecipitates	NULL
were	NULL
fractionated	NULL
by	NULL
reducing	NULL
SDS-PAGE	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
relative	NULL
positions	NULL
and	NULL
sizes	NULL
(	NULL
in	NULL
kilodaltons	NULL
)	NULL
of	NULL
molecular	NULL
weight	NULL
standards	NULL
are	NULL
given	NULL
on	NULL
the	NULL
left	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
IxB/MAD-3	NULL
.	NULL

the	NULL
wild-type	NULL
protein	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
similar	NULL
titrations	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
in	NULL
cells	NULL
containing	NULL
p65	NULL
ANLS	NULL
failed	NULL
to	NULL
significantly	NULL
block	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
lanes	NULL
7-10	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5B	NULL
,	NULL
coimmunoprecipitation	NULL
studies	NULL
Eerformed	NULL
with	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
p65-specific	NULL
antiserum	NULL
and	NULL
**S-labeled	NULL
extracts	NULL
derived	NULL
from	NULL
these	NULL
cells	NULL
showed	NULL
markedly	NULL
diminished	NULL
I	NULL
«	NULL
B/MAD-3	NULL
binding	NULL
to	NULL
the	NULL
p65	NULL
ANLS	NULL
protein	NULL
(	NULL
lanes	NULL
7-10	NULL
)	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
protein	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
6A	NULL
,	NULL
deletion	NULL
of	NULL
four	NULL
amino	NULL
acids	NULL
immediately	NULL
N-terminal	NULL
(	NULL
p65	NULL
A297-300	NULL
;	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
eight	NULL
amino	NULL
acids	NULL
C-terminal	NULL
(	NULL
p65	NULL
A305-312	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
to	NULL
the	NULL
KRKR	NULL
motif	NULL
(	NULL
deleted	NULL
in	NULL
lane	NULL
2	NULL
)	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
the	NULL
IxB/MAD-3	NULL
binding	NULL
capacity	NULL
of	NULL
these	NULL
mutant	NULL
proteins	NULL
.	NULL

Site-directed	NULL
mutation	NULL
of	NULL
the	NULL
nearby	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
phosphorylation	NULL
consensus	NULL
sequence	NULL
(	NULL
RRPS	NULL
;	NULL
amino	NULL
acids	NULL
273-276	NULL
)	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
also	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
interaction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
biochemical	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
KRKR	NULL
motif	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
selectively	NULL
required	NULL
for	NULL
I	NULL
«	NULL
xB-mediated	NULL
inhibition	NULL
and	NULL
functions	NULL
as	NULL
a	NULL
primary	NULL
subregion	NULL
mediating	NULL
the	NULL
stable	NULL
assembly	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
in	NULL
vivo	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
this	NULL
basic	NULL
subregion	NULL
within	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
in	NULL
fact	NULL
a	NULL
functional	NULL
NLS	NULL
,	NULL
immunofluores-	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
December	NULL
1992	NULL
cence	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p65-specific	NULL
antiserum	NULL
and	NULL
COS	NULL
cell	NULL
transfectants	NULL
overexpressing	NULL
either	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
p65	NULL
Rel	NULL
;	NULL
amino	NULL
acids	NULL
1-312	NULL
)	NULL
or	NULL
a	NULL
variant	NULL
of	NULL
this	NULL
terminal	NULL
deletion	NULL
mutant	NULL
lacking	NULL
the	NULL
KRKR	NULL
motif	NULL
,	NULL
termed	NULL
p65	NULL
Rel	NULL
AKRKR	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
preliminary	NULL
studies	NULL
performed	NULL
with	NULL
the	NULL
full-length	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
revealed	NULL
a	NULL
predominantly	NULL
perinuclear	NULL
or	NULL
whole-cell	NULL
pattern	NULL
of	NULL
fluorescence	NULL
(	NULL
see	NULL
Figure	NULL
2C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
C-terminus	NULL
intrinsically	NULL
influences	NULL
the	NULL
subcellular	NULL
disposition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
6B	NULL
,	NULL
immunofluorescence	NULL
staining	NULL
of	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
C-terminal	NULL
deletion	NULL
mutant	NULL
truncated	NULL
downstream	NULL
of	NULL
the	NULL
KRKR	NULL
motif	NULL
(	NULL
p65	NULL
Rel	NULL
)	NULL
clearly	NULL
demonstrated	NULL
a	NULL
nuclear	NULL
pattern	NULL
of	NULL
expression	NULL
.	NULL

Selective	NULL
deletion	NULL
of	NULL
the	NULL
KRKR	NULL
motif	NULL
within	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutant	NULL
profoundly	NULL
altered	NULL
the	NULL
subcellular	NULL
distribution	NULL
,	NULL
yielding	NULL
a	NULL
polypeptide	NULL
(	NULL
p65	NULL
Rel	NULL
AKRKR	NULL
)	NULL
confined	NULL
predominantly	NULL
to	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
a	NULL
mutant	NULL
substituted	NULL
within	NULL
the	NULL
KRKR	NULL
domain	NULL
(	NULL
KRKR	NULL
~-AAAA	NULL
;	NULL
Ganchi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
deletion	NULL
of	NULL
a	NULL
region	NULL
adjacent	NULL
to	NULL
the	NULL
KRKR	NULL
motif	NULL
(	NULL
p65	NULL
Rel	NULL
A293-296	NULL
)	NULL
failed	NULL
to	NULL
disrupt	NULL
the	NULL
nuclear	NULL
targeting	NULL
of	NULL
this	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
construct	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
the	NULL
NLS	NULL
function	NULL
of	NULL
this	NULL
motif	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

1347	NULL
P.A	NULL
.	NULL

Ganchi	NULL
et	NULL
al	NULL
.	NULL

p65	NULL
Rel	NULL
A293-296	NULL
p65	NULL
Rel	NULL
AKRKR	NULL
>	NULL
-	NULL
NIB	NULL
dean	NULL
GMD	NULL
cums	NULL
cuse	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
The	NULL
functional	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
specifically	NULL
targeted	NULL
by	NULL
IxB/MAD-3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Neither	NULL
the	NULL
conserved	NULL
PKA	NULL
site	NULL
nor	NULL
the	NULL
sequences	NULL
flanking	NULL
the	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
association	NULL
with	NULL
I	NULL
«	NULL
B/MAD-3	NULL
.	NULL

Extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
I	NULL
«	NULL
B/MAD-3	NULL
together	NULL
with	NULL
p65	NULL
A297-300	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
p65	NULL
ANLS	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
p65	NULL
A305-312	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
p65	NULL
PKA	NULL
S5	NULL
-	NULL
»	NULL
A	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
p65	NULL
PKA	NULL
S	NULL
-	NULL
»	NULL
G	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
an	NULL
antipeptide	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
C-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
535-551	NULL
)	NULL
.	NULL

Immune	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gel	NULL
and	NULL
visualized	NULL
by	NULL
fluorography	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
closed	NULL
arrowhead	NULL
)	NULL
and	NULL
IkB/MAD-3	NULL
(	NULL
open	NULL
arrowhead	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
highly	NULL
conserved	NULL
KRKR	NULL
motif	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
serves	NULL
as	NULL
a	NULL
functional	NULL
nuclear	NULL
localization	NULL
signal	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
either	NULL
p65	NULL
Rel	NULL
,	NULL
p65	NULL
Rel	NULL
AKRKR	NULL
,	NULL
or	NULL
p65	NULL
Rel	NULL
A293-296	NULL
,	NULL
fixed	NULL
48	NULL
h	NULL
posttransfection	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
an	NULL
antipeptide	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
N-terminus	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
1-21	NULL
)	NULL
.	NULL

Complexes	NULL
were	NULL
visualized	NULL
using	NULL
a	NULL
Texas	NULL
red-conjugated	NULL
second	NULL
antibody	NULL
.	NULL

DISCUSSION	NULL
The	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
,	NULL
a	NULL
prominent	NULL
member	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
both	NULL
the	NULL
physiologic	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
``	NULL
immunologic	NULL
stimuli	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986a	NULL
,	NULL
b	NULL
;	NULL
Lenardo	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
)	NULL
and	NULL
the	NULL
pathologic	NULL
induction	NULL
of	NULL
HIV-1	NULL
gene	NULL
expression	NULL
in	NULL
infected	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
(	NULL
Muesing	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Nabel	NULL
and	NULL
Baltimore	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

The	NULL
prototypic	NULL
form	NULL
of	NULL
this	NULL
heterodimeric	NULL
complex	NULL
is	NULL
composed	NULL
of	NULL
two	NULL
functionally	NULL
distinct	NULL
subunits	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
which	NULL
share	NULL
extensive	NULL
N-terminal	NULL
homology	NULL
with	NULL
the	NULL
v-rel	NULL
oncogene	NULL
product	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
(	NULL
Gilmore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
other	NULL
interactive	NULL
Rel-related	NULL
polypeptides	NULL
recently	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
may	NULL
also	NULL
participate	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
signal	NULL
transduc-tion	NULL
pathway	NULL
through	NULL
combinatorial	NULL
associations	NULL
involving	NULL
either	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Neri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Schmid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Bours	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
;	NULL
Ryseck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Although	NULL
only	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
was	NULL
originally	NULL
believed	NULL
to	NULL
possess	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
)	NULL
,	NULL
recent	NULL
studies	NULL
clearly	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
a	NULL
«	NULL
B-specific	NULL
enhancer-binding	NULL
protein	NULL
in	NULL
its	NULL
own	NULL
right	NULL
(	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

However	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
differs	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
with	NULL
respect	NULL
to	NULL
several	NULL
important	NULL
functions	NULL
.	NULL

Specifically	NULL
,	NULL
1348	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
contains	NULL
a	NULL
strong	NULL
transactivation	NULL
domain	NULL
at	NULL
its	NULL
C-terminus	NULL
that	NULL
is	NULL
conspicuously	NULL
absent	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
in	NULL
vitro	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
but	NULL
not	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
is	NULL
selectively	NULL
inhibited	NULL
by	NULL
IxB	NULL
,	NULL
a	NULL
known	NULL
cytosolic	NULL
antagonist	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Urban	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Zabel	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
;	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
several	NULL
cDNAs	NULL
encoding	NULL
I	NULL
«	NULL
B-like	NULL
inhibitors	NULL
recently	NULL
have	NULL
been	NULL
cloned	NULL
,	NULL
including	NULL
human	NULL
MAD-3	NULL
(	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
chicken	NULL
pp40	NULL
(	NULL
Davis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
murine	NULL
I	NULL
«	NULL
By	NULL
(	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
)	NULL
,	NULL
and	NULL
human	NULL
Bcl-3	NULL
(	NULL
Ohno	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Hatada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Wulezyn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
high	NULL
degree	NULL
of	NULL
amino	NULL
acid	NULL
sequence	NULL
homology	NULL
shared	NULL
among	NULL
these	NULL
various	NULL
inhibitors	NULL
,	NULL
such	NULL
as	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
ankyrin-like	NULL
motifs	NULL
(	NULL
Davis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Haskill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
)	NULL
,	NULL
suggests	NULL
a	NULL
family	NULL
of	NULL
related	NULL
proteins	NULL
that	NULL
may	NULL
differentially	NULL
regulate	NULL
one	NULL
or	NULL
more	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
transcription	NULL
factor	NULL
pathway	NULL
.	NULL

Furthermore	NULL
,	NULL
recent	NULL
mutational	NULL
analyses	NULL
clearly	NULL
have	NULL
demonstrated	NULL
that	NULL
four	NULL
of	NULL
the	NULL
ankyrin	NULL
repeats	NULL
present	NULL
in	NULL
pp40	NULL
are	NULL
required	NULL
to	NULL
mediate	NULL
its	NULL
inhibitory	NULL
effect	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
corresponding	NULL
sequences	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
that	NULL
interface	NULL
with	NULL
these	NULL
I	NULL
«	NULL
B	NULL
binding	NULL
determinants	NULL
and	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
interaction	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
p65-dependent	NULL
transcription	NULL
in	NULL
vivo	NULL
have	NULL
remained	NULL
unknown	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL
Interactions	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
p65	NULL
and	NULL
I	NULL
«	NULL
B/MAD-3	NULL
PKA	NULL
NLS	NULL
(	NULL
RRPS	NULL
)	NULL
-	NULL
(	NULL
KRKR	NULL
)	NULL
NH	NULL
2	NULL
.~	NULL
.	NULL

Rel	NULL
Homology	NULL
Domain	NULL
100	NULL
211	NULL
2191	NULL
DNA	NULL
Binding	NULL
aft	NULL
___I	NULL
``	NULL
151	NULL
IxB	NULL
Binding	NULL
Required	NULL
for	NULL
IxB-Mediated	NULL
Inhibition	NULL
312	NULL
Figure	NULL
7	NULL
.	NULL

-	NULL
Defined	NULL
organization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
functionally	NULL
bipartite	NULL
I	NULL
«	NULL
B/MAD-3	NULL
receptor	NULL
sequences	NULL
.	NULL

Established	NULL
amino	NULL
acid	NULL
endpoints	NULL
for	NULL
the	NULL
maximal	NULL
DNA	NULL
binding	NULL
(	NULL
amino	NULL
acids	NULL
21-291	NULL
)	NULL
and	NULL
I	NULL
«	NULL
B/MAD-3	NULL
binding	NULL
(	NULL
amino	NULL
acids	NULL
151-312	NULL
)	NULL
domains	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
are	NULL
shown	NULL
in	NULL
relation	NULL
to	NULL
previously	NULL
defined	NULL
motifs	NULL
(	NULL
see	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

The	NULL
region	NULL
within	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transactivation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
450-500	NULL
)	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
IxB-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
is	NULL
also	NULL
bracketed	NULL
.	NULL

explored	NULL
in	NULL
detail	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
specific	NULL
interaction	NULL
between	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
IxB/MAD-3	NULL
,	NULL
focusing	NULL
on	NULL
defining	NULL
the	NULL
requisite	NULL
interaction	NULL
sequences	NULL
within	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
binding	NULL
on	NULL
the	NULL
various	NULL
intrinsic	NULL
biochemical	NULL
properties	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

IxB	NULL
/MAD-3	NULL
Inhibits	NULL
NF-	NULL
«	NULL
B	NULL
p65-Dependent	NULL
Transcription	NULL
In	NULL
Vivo	NULL
Previous	NULL
functional	NULL
assays	NULL
performed	NULL
with	NULL
Gal4/NF-	NULL
«	NULL
B	NULL
p65	NULL
chimeric	NULL
proteins	NULL
identified	NULL
a	NULL
potent	NULL
transactivation	NULL
domain	NULL
in	NULL
the	NULL
distal	NULL
101	NULL
amino	NULL
acids	NULL
of	NULL
this	NULL
65-kDa	NULL
subunit	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Ballard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Transient	NULL
expression	NULL
studies	NULL
in	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
using	NULL
the	NULL
wild-type	NULL
and	NULL
C-terminally	NULL
truncated	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
show	NULL
that	NULL
these	NULL
activation	NULL
sequences	NULL
also	NULL
function	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
native	NULL
protein	NULL
and	NULL
that	NULL
IxB/MAD-3	NULL
completely	NULL
negates	NULL
their	NULL
stimulatory	NULL
effects	NULL
on	NULL
transcription	NULL
in	NULL
vivo	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
I	NULL
«	NULL
xB-mediated	NULL
inhibition	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
selective	NULL
deletion	NULL
of	NULL
a	NULL
mini-leucine	NULL
zipper	NULL
motif	NULL
that	NULL
has	NULL
been	NULL
implicated	NULL
as	NULL
a	NULL
part	NULL
of	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
MAD-3	NULL
represents	NULL
at	NULL
least	NULL
one	NULL
functional	NULL
member	NULL
of	NULL
the	NULL
proposed	NULL
IxB	NULL
family	NULL
of	NULL
polypeptides	NULL
that	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
regulate	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
-dependent	NULL
transcription	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
the	NULL
Primary	NULL
Functional	NULL
Target	NULL
of	NULL
IxB/MAD-3	NULL
Phenotypic	NULL
analysis	NULL
of	NULL
a	NULL
series	NULL
of	NULL
N-	NULL
and	NULL
C-terminal	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
truncation	NULL
mutants	NULL
has	NULL
localized	NULL
the	NULL
maximal	NULL
I	NULL
«	NULL
xB/MAD-3	NULL
binding	NULL
domain	NULL
to	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
encompassing	NULL
amino	NULL
acids	NULL
151	NULL
through	NULL
312	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

This	NULL
region	NULL
includes	NULL
a	NULL
basic	NULL
tetrapeptide	NULL
motif	NULL
(	NULL
KRKR	NULL
;	NULL
amino	NULL
acids	NULL
301-304	NULL
;	NULL
Figure	NULL
7	NULL
)	NULL
(	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
that	NULL
is	NULL
highly	NULL
conserved	NULL
among	NULL
all	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
polypeptide	NULL
family	NULL
(	NULL
Gil-	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
December	NULL
1992	NULL
more	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
the	NULL
corresponding	NULL
motif	NULL
within	NULL
the	NULL
110-kDa	NULL
precursor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
RKRQK	NULL
)	NULL
serves	NULL
as	NULL
a	NULL
functional	NULL
NLS	NULL
whose	NULL
expression	NULL
is	NULL
effectively	NULL
masked	NULL
in	NULL
cis	NULL
by	NULL
inhibitory	NULL
C-terminal	NULL
sequences	NULL
(	NULL
Blank	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Henkel	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

These	NULL
inhibitory	NULL
precursor	NULL
sequences	NULL
are	NULL
ultimately	NULL
removed	NULL
by	NULL
proteolytic	NULL
process-ing	NULL
,	NULL
thereby	NULL
generating	NULL
the	NULL
mature	NULL
50-kDa	NULL
DNA	NULL
binding	NULL
protein	NULL
(	NULL
Ghosh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kieran	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

An	NULL
alternatively	NULL
spliced	NULL
transcript	NULL
selectively	NULL
encoding	NULL
this	NULL
C-terminal	NULL
inhibitory	NULL
domain	NULL
,	NULL
termed	NULL
recently	NULL
has	NULL
been	NULL
cloned	NULL
and	NULL
shown	NULL
to	NULL
exhibit	NULL
IxB-like	NULL
activity	NULL
in	NULL
trans	NULL
(	NULL
Inoue	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992a	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
the	NULL
basic	NULL
KRKR	NULL
motif	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
a	NULL
functional	NULL
NLS	NULL
.	NULL

Furthermore	NULL
,	NULL
specific	NULL
deletion	NULL
of	NULL
this	NULL
NLS	NULL
markedly	NULL
reduces	NULL
the	NULL
capacity	NULL
of	NULL
IxB/MAD-3	NULL
to	NULL
stably	NULL
associate	NULL
with	NULL
this	NULL
transactivator	NULL
protein	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
I	NULL
«	NULL
B/MAD-3	NULL
directly	NULL
binds	NULL
to	NULL
and	NULL
masks	NULL
the	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
thereby	NULL
preventing	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
from	NULL
entering	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

The	NULL
highly	NULL
conserved	NULL
nature	NULL
of	NULL
this	NULL
NLS	NULL
among	NULL
the	NULL
various	NULL
known	NULL
Rel	NULL
proteins	NULL
underscores	NULL
a	NULL
potentially	NULL
fundamental	NULL
role	NULL
for	NULL
this	NULL
basic	NULL
motif	NULL
in	NULL
regulating	NULL
the	NULL
inducible	NULL
nuclear	NULL
import	NULL
of	NULL
multiple	NULL
Rel	NULL
family	NULL
members	NULL
via	NULL
recognition	NULL
by	NULL
IkB	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
now	NULL
show	NULL
that	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
is	NULL
also	NULL
regulated	NULL
by	NULL
IxB/MAD-3	NULL
,	NULL
presumably	NULL
by	NULL
a	NULL
similar	NULL
mechanism	NULL
that	NULL
involves	NULL
masking	NULL
of	NULL
its	NULL
NLS	NULL
(	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
suggest	NULL
that	NULL
the	NULL
homodimeric	NULL
form	NULL
of	NULL
this	NULL
Rel-related	NULL
subunit	NULL
acts	NULL
specifically	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65-dependent	NULL
transcription	NULL
from	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
(	NULL
Kang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
yet	NULL
clear	NULL
whether	NULL
I	NULL
«	NULL
By	NULL
,	NULL
IxB/MAD-3	NULL
,	NULL
or	NULL
another	NULL
member	NULL
of	NULL
this	NULL
growing	NULL
family	NULL
of	NULL
repressors	NULL
is	NULL
the	NULL
authentic	NULL
physiologic	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
function	NULL
.	NULL

Notwithstanding	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
C-terminus	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
precursor	NULL
to	NULL
mask	NULL
its	NULL
own	NULL
NLS	NULL
,	NULL
coupled	NULL
with	NULL
its	NULL
homology	NULL
to	NULL
both	NULL
IxBy	NULL
and	NULL
I	NULL
«	NULL
B/MAD-3	NULL
,	NULL
suggests	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
NLS	NULL
plays	NULL
a	NULL
1349	NULL
P.A	NULL
.	NULL

Ganchi	NULL
et	NULL
al	NULL
.	NULL

role	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
NLS	NULL
in	NULL
IxB-de-pendent	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

The	NULL
Unique	NULL
C-terminal	NULL
Half	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
Attenuates	NULL
the	NULL
Rel	NULL
Domain-Encoded	NULL
Functions	NULL
of	NULL
DNA	NULL
Binding	NULL
and	NULL
Nuclear	NULL
Localization	NULL
Transactivation	NULL
In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
deletion	NULL
mutants	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
devoid	NULL
of	NULL
the	NULL
unique	NULL
C-terminal	NULL
sequences	NULL
are	NULL
more	NULL
efficiently	NULL
localized	NULL
within	NULL
the	NULL
nucleus	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
protein	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
these	NULL
transcriptionally	NULL
inactive	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
mutants	NULL
also	NULL
bind	NULL
DNA	NULL
with	NULL
increased	NULL
affinity	NULL
(	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
recently	NULL
recognized	NULL
capacity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
to	NULL
induce	NULL
I	NULL
«	NULL
B/MAD-3	NULL
gene	NULL
expression	NULL
(	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
results	NULL
)	NULL
may	NULL
contribute	NULL
to	NULL
these	NULL
functional	NULL
effects	NULL
.	NULL

Alternatively	NULL
these	NULL
effects	NULL
could	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
disruption	NULL
of	NULL
non-covalent	NULL
interactions	NULL
that	NULL
occur	NULL
between	NULL
the	NULL
C-terminus	NULL
of	NULL
NFE-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
the	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

In	NULL
what	NULL
may	NULL
be	NULL
a	NULL
related	NULL
finding	NULL
,	NULL
specific	NULL
deletion	NULL
of	NULL
the	NULL
NLS	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
also	NULL
enhances	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
stretch	NULL
of	NULL
basic	NULL
residues	NULL
may	NULL
serve	NULL
as	NULL
a	NULL
primary	NULL
contact	NULL
point	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
C-terminus	NULL
.	NULL

This	NULL
proposed	NULL
type	NULL
of	NULL
intramolecular	NULL
masking	NULL
mechanism	NULL
is	NULL
not	NULL
without	NULL
precedent	NULL
.	NULL

For	NULL
example	NULL
,	NULL
as	NULL
noted	NULL
above	NULL
,	NULL
the	NULL
NLS	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
precursor	NULL
is	NULL
functionally	NULL
sequestered	NULL
by	NULL
cis-acting	NULL
C-terminal	NULL
sequences	NULL
(	NULL
Blank	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
C-terminally	NULL
truncated	NULL
variants	NULL
of	NULL
the	NULL
Rel-related	NULL
dorsal	NULL
gene	NULL
product	NULL
,	NULL
a	NULL
maternal	NULL
morphogen	NULL
in	NULL
Drosophila	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
exhibit	NULL
enhanced	NULL
nuclear	NULL
localization	NULL
properties	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
wild-type	NULL
protein	NULL
(	NULL
Rushlow	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
cell	NULL
cycle-dependent	NULL
nuclear	NULL
import	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
,	NULL
SWI5	NULL
,	NULL
is	NULL
contingent	NULL
on	NULL
the	NULL
regulated	NULL
disruption	NULL
of	NULL
an	NULL
intramolecular	NULL
salt	NULL
bridge	NULL
involving	NULL
its	NULL
NLS	NULL
(	NULL
Moll	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

By	NULL
analogy	NULL
,	NULL
an	NULL
interplay	NULL
between	NULL
the	NULL
modular	NULL
N-	NULL
and	NULL
C-terminal	NULL
domains	NULL
in	NULL
NF-kB	NULL
p65	NULL
may	NULL
represent	NULL
an	NULL
alternative	NULL
mechanism	NULL
for	NULL
regulating	NULL
the	NULL
potent	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
in	NULL
an	NULL
IxB-independent	NULL
manner	NULL
.	NULL

This	NULL
inhibitory	NULL
interaction	NULL
could	NULL
conceivably	NULL
be	NULL
relieved	NULL
by	NULL
dimerization	NULL
with	NULL
other	NULL
Rel	NULL
polypeptides	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
)	NULL
or	NULL
by	NULL
specific	NULL
posttranslational	NULL
modification	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
phosphoryla-tion	NULL
)	NULL
that	NULL
induces	NULL
an	NULL
``	NULL
open	NULL
'	NULL
``	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
structural	NULL
con-figuration	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
Transactivation	NULL
Domain	NULL
and	NULL
NLS	NULL
are	NULL
Essential	NULL
for	NULL
a	NULL
Fully	NULL
Functional	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
/IxB	NULL
Interaction	NULL
Although	NULL
the	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
is	NULL
fully	NULL
capable	NULL
of	NULL
binding	NULL
I	NULL
«	NULL
B/MAD-3	NULL
,	NULL
I	NULL
«	NULL
B-mediated	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
requires	NULL
additional	NULL
sequences	NULL
that	NULL
map	NULL
to	NULL
the	NULL
remote	NULL
1350	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
.	NULL

This	NULL
relationship	NULL
explains	NULL
the	NULL
paradoxical	NULL
finding	NULL
that	NULL
IxB/MAD-3	NULL
efficiently	NULL
engages	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
but	NULL
inhibits	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
only	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
see	NULL
Figure	NULL
2	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Specifically	NULL
,	NULL
these	NULL
selective	NULL
inhibitory	NULL
effects	NULL
of	NULL
IxB/MAD-3	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
do	NULL
not	NULL
derive	NULL
from	NULL
subtle	NULL
differences	NULL
between	NULL
the	NULL
Rel	NULL
homology	NULL
domains	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
(	NULL
Nolan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
but	NULL
rather	NULL
involve	NULL
the	NULL
unique	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
,	NULL
which	NULL
is	NULL
missing	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

Coupled	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
can	NULL
be	NULL
regulated	NULL
by	NULL
IxB/MAD-3	NULL
,	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
itself	NULL
can	NULL
be	NULL
considered	NULL
an	NULL
IxB-resistant	NULL
DNA	NULL
binding	NULL
unit	NULL
containing	NULL
an	NULL
IxB-sensitive	NULL
NLS	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
to	NULL
block	NULL
DNA	NULL
binding	NULL
activity	NULL
depends	NULL
critically	NULL
on	NULL
C-terminal	NULL
sequences	NULL
downstream	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
which	NULL
are	NULL
highly	NULL
divergent	NULL
among	NULL
the	NULL
various	NULL
NF-	NULL
«	NULL
B/	NULL
Rel	NULL
polypeptides	NULL
(	NULL
Gilmore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
ability	NULL
of	NULL
I	NULL
«	NULL
B/MAD-3	NULL
to	NULL
control	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
at	NULL
the	NULL
level	NULL
of	NULL
subcellular	NULL
localization	NULL
,	NULL
this	NULL
alternate	NULL
inhibitory	NULL
potential	NULL
would	NULL
seem	NULL
redundant	NULL
.	NULL

However	NULL
,	NULL
should	NULL
I	NULL
«	NULL
B/MAD-3	NULL
gain	NULL
access	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
its	NULL
capacity	NULL
to	NULL
inhibit	NULL
DNA	NULL
binding	NULL
may	NULL
serve	NULL
a	NULL
pivotal	NULL
role	NULL
in	NULL
promoting	NULL
disengagement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
bound	NULL
to	NULL
its	NULL
cognate	NULL
enhancer	NULL
(	NULL
Zabel	NULL
and	NULL
Baeuerle	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
activity	NULL
has	NULL
been	NULL
identified	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
T	NULL
lymphocytes	NULL
and	NULL
further	NULL
shown	NULL
to	NULL
be	NULL
highly	NULL
sensitive	NULL
to	NULL
treatment	NULL
with	NULL
deoxycholate	NULL
(	NULL
Kang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
a	NULL
characteristic	NULL
biochemical	NULL
property	NULL
of	NULL
IxB	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

As	NULL
such	NULL
,	NULL
through	NULL
its	NULL
dual	NULL
capacity	NULL
to	NULL
block	NULL
nuclear	NULL
import	NULL
as	NULL
well	NULL
as	NULL
DNA	NULL
binding	NULL
,	NULL
IB	NULL
could	NULL
control	NULL
both	NULL
the	NULL
rapid	NULL
mobilization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
subsequent	NULL
termination	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65-dependent	NULL
transcription	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Karen	NULL
Koerber	NULL
,	NULL
Paul	NULL
Morrow	NULL
,	NULL
Nancy	NULL
Peffer	NULL
,	NULL
and	NULL
Eric	NULL
Dixon	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
;	NULL
Dr.	NULL
C.	NULL
Rosen	NULL
for	NULL
the	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
clone	NULL
;	NULL
Dr.	NULL
A.	NULL
Baldwin	NULL
for	NULL
the	NULL
human	NULL
I	NULL
«	NULL
B/MAD-3	NULL
clone	NULL
;	NULL
Dr.	NULL
B.	NULL
Stein	NULL
for	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
construct	NULL
;	NULL
and	NULL
Diane	NULL
Gearhart	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

P.	NULL
Ganchi	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
NIH	NULL
training	NULL
grant	NULL
5T32CA-09111	NULL
.	NULL

This	NULL
work	NULL
was	NULL
funded	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
NIH	NULL
(	NULL
5RO-1AI-29117-05	NULL
)	NULL
and	NULL
the	NULL
J.	NULL
David	NULL
Gladstone	NULL
Institutes	NULL
.	NULL

REFERENCES	NULL
Andersson	NULL
,	NULL
S.	NULL
,	NULL
Davis	NULL
,	NULL
D.	NULL
,	NULL
Dahlback	NULL
,	NULL
H.	NULL
,	NULL
Jornvail	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Russell	NULL
,	NULL
D.W.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Cloning	NULL
structure	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mitochondrial	NULL
cytochrome	NULL
P-450	NULL
sterol	NULL
26-hydroxylase	NULL
,	NULL
a	NULL
bile	NULL
acid	NULL
biosynthetic	NULL
en-zyme	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
8222-8229	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988a	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53	NULL
,	NULL
211-217	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1988b	NULL
)	NULL
.	NULL

I	NULL
«	NULL
B	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242	NULL
,	NULL
541-546	NULL
.	NULL

Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3	NULL
,	NULL
1689-1698	NULL
.	NULL

Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Hoffman	NULL
,	NULL
J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Dixon	NULL
,	NULL
E.P	NULL
.	NULL

,	NULL
Franza	NULL
,	NULL
B.R	NULL
.	NULL

,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
gene	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
DNA-protein	NULL
interactions	NULL
flanking	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

1	NULL
,	NULL
83-92	NULL
.	NULL

Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
Dixon	NULL
,	NULL
E.P	NULL
.	NULL

,	NULL
Peffer	NULL
,	NULL
N.J.	NULL
,	NULL
Bogerd	NULL
,	NULL
H.	NULL
,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Stein	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-Rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
1875-1879	NULL
.	NULL

Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
Walker	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Dixon	NULL
,	NULL
E.P	NULL
.	NULL

,	NULL
Peffer	NULL
,	NULL
N.J.	NULL
,	NULL
Hannink	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
v-rel	NULL
oncogene	NULL
encodes	NULL
a	NULL
«	NULL
B	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Cell	NULL
63	NULL
,	NULL
803-814	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Cytoplasmic	NULL
retention	NULL
,	NULL
DNA-binding	NULL
and	NULL
processing	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
precursor	NULL
are	NULL
controlled	NULL
by	NULL
a	NULL
small	NULL
region	NULL
in	NULL
its	NULL
C-terminus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
4159-4167	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
Franza	NULL
,	NULL
B.R	NULL
.	NULL

,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
regulates	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
receptor-alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
53	NULL
,	NULL
827-836	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
Burd	NULL
,	NULL
P.R	NULL
.	NULL

,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
Villalobos	NULL
,	NULL
J.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50/p105-NF-	NULL
«	NULL
B	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
«	NULL
B	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
685-695	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
(	NULL
1976	NULL
)	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
,	NULL
248-254	NULL
.	NULL

Brady	NULL
,	NULL
J.	NULL
,	NULL
Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
Duvall	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Khoury	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
p40*-responsive	NULL
regulatory	NULL
sequences	NULL
within	NULL
the	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61	NULL
,	NULL
2175-2181	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lym-phocyte	NULL
activation	NULL
.	NULL

Science	NULL
243	NULL
,	NULL
355-361	NULL
.	NULL

Davis	NULL
,	NULL
N.	NULL
,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Baltimore	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Bose	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Rel-associated	NULL
pp40	NULL
:	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Science	NULL
253	NULL
,	NULL
1268-1271	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Gifford	NULL
,	NULL
A.M.	NULL
,	NULL
Riviere	NULL
,	NULL
LR	NULL
.	NULL

,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62	NULL
,	NULL
1019-1029	NULL
.	NULL

Gilmore	NULL
,	NULL
T.D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
,	NULL
KBF1	NULL
,	NULL
dorsal	NULL
,	NULL
and	NULL
related	NULL
matters	NULL
.	NULL

Cell	NULL
62	NULL
,	NULL
841-843	NULL
.	NULL

Gilmore	NULL
,	NULL
TD	NULL
.	NULL

,	NULL
and	NULL
Temin	NULL
,	NULL
H.M.	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

v-rel	NULL
oncoproteins	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
in	NULL
the	NULL
cytoplasm	NULL
transform	NULL
chicken	NULL
spleen	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
703-714	NULL
.	NULL

Greene	NULL
,	NULL
W.C.	NULL
,	NULL
Bohniein	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Ballard	NULL
,	NULL
D.W.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

HIV-1	NULL
,	NULL
HTLV-I	NULL
and	NULL
normal	NULL
T-cell	NULL
growth	NULL
:	NULL
transcriptional	NULL
strategies	NULL
and	NULL
surprises	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10	NULL
,	NULL
272-278	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A.A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Morris	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Yurochko	NULL
,	NULL
A.D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.S.	NULL
,	NULL
Jr.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
I	NULL
«	NULL
B-like	NULL
activity	NULL
.	NULL

Cell	NULL
65	NULL
,	NULL
1281-1289	NULL
.	NULL

Hatada	NULL
,	NULL
EN	NULL
.	NULL

,	NULL
Nieters	NULL
,	NULL
A.	NULL
,	NULL
Wulezyn	NULL
,	NULL
F.G.	NULL
,	NULL
Naumann	NULL
,	NULL
M.	NULL
,	NULL
Meyer	NULL
,	NULL
R.	NULL
,	NULL
Nucifora	NULL
,	NULL
G.	NULL
,	NULL
McKeithan	NULL
,	NULL
TW	NULL
.	NULL

,	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
ankyrin	NULL
repeat	NULL
domains	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
precursor	NULL
p105	NULL
and	NULL
the	NULL
protooncogene	NULL
bcl-3	NULL
act	NULL
as	NULL
specific	NULL
inhibitors	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
DNA	NULL
binding	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
2489-2493	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Zabel	NULL
,	NULL
U.	NULL
,	NULL
van	NULL
Zee	NULL
,	NULL
K.	NULL
,	NULL
Miiller	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Fanning	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Intramolecular	NULL
masking	NULL
of	NULL
the	NULL
nuclear	NULL
location	NULL
Vol	NULL
.	NULL

3	NULL
,	NULL
December	NULL
1992	NULL
Interactions	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
IxB/MAD-3	NULL
signal	NULL
and	NULL
dimerization	NULL
domain	NULL
in	NULL
the	NULL
precursor	NULL
for	NULL
the	NULL
p50	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
.	NULL

Cell	NULL
68	NULL
,	NULL
1121-1133	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
,	NULL
Gulino	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ruscetti	NULL
,	NULL
F.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Cis-acting	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
gibbon	NULL
ape	NULL
leukemia	NULL
virus	NULL
(	NULL
GALV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Virology	NULL
157	NULL
,	NULL
211-219	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244	NULL
,	NULL
457-460	NULL
.	NULL

Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
Kerr	NULL
,	NULL
L.D	NULL
.	NULL

,	NULL
Kakizuka	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

(	NULL
19922	NULL
)	NULL
.	NULL

IxBy	NULL
,	NULL
a	NULL
70	NULL
kd	NULL
protein	NULL
identical	NULL
to	NULL
the	NULL
C-terminal	NULL
half	NULL
of	NULL
p110	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

Cell	NULL
68	NULL
,	NULL
1109-1120	NULL
.	NULL

Inoue	NULL
,	NULL
J.-I	NULL
.	NULL

,	NULL
Kerr	NULL
,	NULL
LD	NULL
.	NULL

,	NULL
Rashid	NULL
,	NULL
D.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Bose	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Jr.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

(	NULL
1992b	NULL
)	NULL
.	NULL

Direct	NULL
association	NULL
of	NULL
pp40/I	NULL
«	NULL
B8	NULL
with	NULL
rel/NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
:	NULL
role	NULL
of	NULL
ankyrin	NULL
repeats	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
4333-4337	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
Tran	NULL
,	NULL
A.-C.	NULL
,	NULL
Grilli	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.J.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256	NULL
,	NULL
1452-1456	NULL
.	NULL

Kaufman	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Valanora	NULL
,	NULL
G.	NULL
,	NULL
Rodriguez	NULL
,	NULL
G.	NULL
,	NULL
Bushar	NULL
,	NULL
G.	NULL
,	NULL
Giri	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Norcross	NULL
,	NULL
M.D	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

Phorbol	NULL
ester	NULL
enhances	NULL
human	NULL
immunodeficiency	NULL
virus-promoted	NULL
gene	NULL
expression	NULL
and	NULL
acts	NULL
on	NULL
a	NULL
repeated	NULL
10-base-pair	NULL
functional	NULL
enhancer	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
3759-3766	NULL
.	NULL

Kerr	NULL
,	NULL
LD	NULL
.	NULL

,	NULL
Inoue	NULL
,	NULL
J.-L.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Link	NULL
,	NULL
E.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Bose	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Jr.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
Rel-associated	NULL
pp40	NULL
protein	NULL
prevents	NULL
DNA	NULL
binding	NULL
of	NULL
Rel	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
relationship	NULL
with	NULL
and	NULL
regulation	NULL
by	NULL
phosphorylation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5	NULL
,	NULL
1464-1476	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
Blank	NULL
,	NULL
V.	NULL
,	NULL
Logeat	NULL
,	NULL
F.	NULL
,	NULL
Vandekerckhove	NULL
,	NULL
J.	NULL
,	NULL
Lottspeich	NULL
,	NULL
F.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Urban	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
Kourilsky	NULL
,	NULL
P.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62	NULL
,	NULL
1007-1018	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

At	NULL
least	NULL
six	NULL
nucleotides	NULL
preceding	NULL
the	NULL
AUG	NULL
initiator	NULL
codon	NULL
enhance	NULL
translation	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

196	NULL
,	NULL
947-950	NULL
.	NULL

Lenardo	NULL
,	NULL
M.J.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

Molitor	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Walker	NULL
,	NULL
W.H	NULL
.	NULL

,	NULL
Doerre	NULL
,	NULL
S.	NULL
,	NULL
Ballard	NULL
,	NULL
D.W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
,	NULL
10028-10032	NULL
.	NULL

Moll	NULL
,	NULL
T.	NULL
,	NULL
Tebb	NULL
,	NULL
G.	NULL
,	NULL
Surana	NULL
,	NULL
U.	NULL
,	NULL
Robitsch	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Nasmyth	NULL
,	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
phosphorylation	NULL
and	NULL
the	NULL
CDC28	NULL
protein	NULL
kinase	NULL
in	NULL
cell	NULL
cycle-regulated	NULL
nuclear	NULL
import	NULL
of	NULL
the	NULL
S.	NULL
cerevisiae	NULL
transcription	NULL
factor	NULL
SW15	NULL
.	NULL

Cell	NULL
66	NULL
,	NULL
743-758	NULL
.	NULL

Muesing	NULL
,	NULL
M.A	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
D.H.	NULL
,	NULL
and	NULL
Capon	NULL
,	NULL
D.J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
mRNA	NULL
accumulation	NULL
by	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
frans-ac-tivator	NULL
protein	NULL
.	NULL

Cell	NULL
48	NULL
,	NULL
691-701	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

Nakamaye	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Eckstein	NULL
,	NULL
F.	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
restriction	NULL
en-donuclease	NULL
Nci	NULL
I	NULL
by	NULL
phosphorothioate	NULL
groups	NULL
and	NULL
its	NULL
application	NULL
to	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14	NULL
,	NULL
9679-9698	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
Chang	NULL
,	NULL
C.-C.	NULL
,	NULL
Lombardi	NULL
,	NULL
L.	NULL
,	NULL
Salina	NULL
,	NULL
M.	NULL
,	NULL
Corradini	NULL
,	NULL
P.	NULL
,	NULL
Maiolo	NULL
,	NULL
A.T.	NULL
,	NULL
Chaganti	NULL
,	NULL
RS.K	NULL
.	NULL

,	NULL
Dalla-Favera	NULL
,	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

B	NULL
cell	NULL
lymphoma-associated	NULL
chromosomal	NULL
translocation	NULL
involves	NULL
candidate	NULL
oncogene	NULL
lyt-10	NULL
,	NULL
homologous	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
.	NULL

Cell	NULL
67	NULL
,	NULL
1075-1087	NULL
.	NULL

Neumann	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Morency	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Russian	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

Bio-techniques	NULL
5	NULL
,	NULL
444-447	NULL
.	NULL

1351	NULL
P.A	NULL
.	NULL

Ganchi	NULL
et	NULL
al	NULL
.	NULL

Nolan	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Ghosh	NULL
,	NULL
S.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Tempst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IkB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
rel-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64	NULL
,	NULL
961-969	NULL
.	NULL

Ohno	NULL
,	NULL
H.	NULL
,	NULL
Takimoto	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
McKeithan	NULL
,	NULL
T.W	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
candidate	NULL
proto-oncogene	NULL
bel-3	NULL
is	NULL
related	NULL
to	NULL
genes	NULL
implicated	NULL
in	NULL
cell	NULL
lineage	NULL
determination	NULL
and	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Cell	NULL
60	NULL
,	NULL
991-997	NULL
.	NULL

Paskalis	NULL
,	NULL
H.	NULL
,	NULL
Felber	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Pavlakis	NULL
,	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Cis-acting	NULL
sequences	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
constitute	NULL
a	NULL
conditional	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
6558-6562	NULL
.	NULL

Rimsky	NULL
,	NULL
L.	NULL
,	NULL
Hauber	NULL
,	NULL
J.	NULL
,	NULL
Dukovich	NULL
,	NULL
M.	NULL
,	NULL
Malim	NULL
,	NULL
M.	NULL
,	NULL
Langlois	NULL
,	NULL
A.	NULL
,	NULL
Cullen	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

Functional	NULL
replacement	NULL
of	NULL
the	NULL
HIV-1	NULL
rev	NULL
protein	NULL
by	NULL
the	NULL
HTLV-I	NULL
rex	NULL
protein	NULL
.	NULL

Nature	NULL
335	NULL
,	NULL
738-740	NULL
.	NULL

Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Dillon	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Schreck	NULL
,	NULL
R.	NULL
,	NULL
Henkel	NULL
,	NULL
T.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251	NULL
,	NULL
1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Klement	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Coleman	NULL
,	NULL
T.A	NULL
.	NULL

,	NULL
Maher	NULL
,	NULL
M.	NULL
,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
19923	NULL
)	NULL
.	NULL

I-Rel	NULL
:	NULL
a	NULL
novel	NULL
rel-related	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
745-760	NULL
.	NULL

Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Narayanan	NULL
,	NULL
R.	NULL
,	NULL
Klement	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Chen	NULL
,	NULL
C.-H.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1992b	NULL
)	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
derivative	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
444-454	NULL
.	NULL

Rushlow	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Han	NULL
,	NULL
K.	NULL
,	NULL
Manley	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
and	NULL
Levine	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
graded	NULL
distribution	NULL
of	NULL
the	NULL
dorsal	NULL
morphogen	NULL
is	NULL
initiated	NULL
by	NULL
selective	NULL
nuclear	NULL
transport	NULL
in	NULL
Drosophila	NULL
.	NULL

Cell	NULL
59	NULL
,	NULL
1165-1177	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Bull	NULL
,	NULL
P.	NULL
,	NULL
Takamiya	NULL
,	NULL
M.	NULL
,	NULL
Bours	NULL
,	NULL
V.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Do-brzanski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

RelB	NULL
,	NULL
a	NULL
new	NULL
Rel	NULL
family	NULL
transcription	NULL
activator	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
p50-NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
674-684	NULL
.	NULL

Schmid	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Perkins	NULL
,	NULL
N.D.	NULL
,	NULL
Duckett	NULL
,	NULL
C.S	NULL
.	NULL

,	NULL
Andrews	NULL
,	NULL
P.C	NULL
.	NULL

,	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
352	NULL
,	NULL
733-736	NULL
.	NULL

Schmitz	NULL
,	NULL
M.L	NULL
.	NULL

,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
respon-	NULL
sible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10	NULL
,	NULL
3805-3817	NULL
.	NULL

1352	NULL
Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986a	NULL
)	NULL
.	NULL

Inducibility	NULL
of	NULL
«	NULL
immunoglobulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986b	NULL
)	NULL
.	NULL

Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

Shimotohno	NULL
,	NULL
K.	NULL
,	NULL
Takano	NULL
,	NULL
M.	NULL
,	NULL
Teruuchi	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miwa	NULL
,	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
.	NULL

Requirement	NULL
of	NULL
multiple	NULL
copies	NULL
of	NULL
a	NULL
21-nucleotide	NULL
sequence	NULL
in	NULL
the	NULL
U3	NULL
regions	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
long	NULL
terminal	NULL
repeats	NULL
for	NULL
trans-acting	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
8112-8116	NULL
.	NULL

Siekevitz	NULL
,	NULL
M.	NULL
,	NULL
Josephs	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
Dukovich	NULL
,	NULL
M.	NULL
,	NULL
Peffer	NULL
,	NULL
N.J.	NULL
,	NULL
Wong-Staal	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
by	NULL
T-cell	NULL
mitogens	NULL
and	NULL
the	NULL
tat-I	NULL
protein	NULL
of	NULL
HTLV-I	NULL
.	NULL

Science	NULL
238	NULL
,	NULL
1575-1578	NULL
.	NULL

Smith	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-I	NULL
tax	NULL
trans-activator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1875-1885	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
,	NULL
Goh	NULL
,	NULL
W.C.	NULL
,	NULL
and	NULL
Haseltine	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
.	NULL

A	NULL
transcriptional	NULL
activator	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
x-lor	NULL
region	NULL
of	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
.	NULL

Science	NULL
228	NULL
,	NULL
1430-1434	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
Rahmsdorf	NULL
,	NULL
H.	NULL
,	NULL
Steffen	NULL
,	NULL
A.	NULL
,	NULL
Litfin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Herrlich	NULL
,	NULL
P.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
metallothionein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
5169-5181	NULL
.	NULL

Tong-Starksen	NULL
,	NULL
S.E	NULL
.	NULL

,	NULL
Luciw	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
and	NULL
Peterin	NULL
,	NULL
BM	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
responds	NULL
to	NULL
T	NULL
cell	NULL
activation	NULL
signals	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
6845-6849	NULL
.	NULL

Urban	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IkB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1975-1984	NULL
.	NULL

Wulezyn	NULL
,	NULL
F.G.	NULL
,	NULL
Naumann	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Scheidereit	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
.	NULL

Candidate	NULL
proto-oncogene	NULL
bel-3	NULL
encodes	NULL
a	NULL
subunit-specific	NULL
inhibitor	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
358	NULL
,	NULL
597-599	NULL
.	NULL

Zabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Purified	NULL
human	NULL
IxB	NULL
can	NULL
rapidly	NULL
dissociate	NULL
the	NULL
complex	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
with	NULL
its	NULL
cognate	NULL
DNA	NULL
.	NULL

Cell	NULL
61	NULL
,	NULL
255-265	NULL
.	NULL

Molecular	NULL
Biology	NULL
of	NULL
the	NULL
Cell	NULL

